Processing 00000000.tx.1: 1995 by The American Society for Biochemistry and Molecular Biology, Inc. 

Phrase: "1995 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."
Processing 00000000.tx.2: Proteolytic Processing of Alzheimers Disease A4 Amyloid Precursor Protein in Human Platelets (*) Qiao-Xin Li , Genevive Evin , David H. 

Phrase: "Proteolytic Processing of Alzheimers Disease A4 Amyloid Precursor Protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1514570:Proteolytic Processing [Molecular Function]
   762   C0033666:protein processing [Molecular Function]
   742   C1709694:Processing [Activity]

Phrase: "in Human Platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "("

Phrase: "*"

Phrase: ")"

Phrase: "Qiao-Xin Li ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Genevive Evin ,"

Phrase: "David H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.3: Small , Gerd Multhaup (1), Konrad Beyreuther (1)(), Colin L. 

Phrase: "Small , Gerd Multhaup"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "Konrad Beyreuther"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "Colin L."
Processing 00000000.tx.4: Masters () From the (1) Department of Pathology, The University of Melbourne, Parkville, Victoria, 3052 Australia, and The Mental Health Research Institute of Victoria, Royal Park Hospital, Parkville, Victoria, 3052 Australia, Center for Molecular Biology, The University of Heidelberg, Heidelberg, D6900 Germany ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS REFERENCES ABSTRACT The processing of amyloid precursor protein (APP) and production of A4 amyloid are events likely to influence the development and progression of Alzheimer's disease, since A4 is the major constituent of amyloid deposited in this disorder. 

Phrase: "Masters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "From the (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587487:Pathology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "The University of Melbourne,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Parkville,"

Phrase: "Victoria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042645:Victoria [Geographic Area]
  1000   C0997115:Victoria [Plant]

Phrase: "3052 Australia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004340:Australia [Geographic Area]
   789 E C0238711:AUSTRALIAN [Finding]

Phrase: "and"

Phrase: "The Mental Health Research Institute of Victoria,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0025353:mental health [Mental Process]
   778   C0035172:Research Institute [Organization]
   778   C1555896:Mental Health [Intellectual Product]
   748   C0018684:Health [Idea or Concept]
   748   C0021622:institute [Organization]
   748   C0035168:research [Research Activity]
   748   C0229992:mental [Mental Process]
   748   C0242481:Research [Research Activity]
   748   C1272753:Institute [Idea or Concept]
   732   C0033876:Psychic Research [Research Activity]

Phrase: "Royal Park Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Parkville,"

Phrase: "Victoria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042645:Victoria [Geographic Area]
  1000   C0997115:Victoria [Plant]

Phrase: "3052 Australia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004340:Australia [Geographic Area]
   789 E C0238711:AUSTRALIAN [Finding]

Phrase: "Center for Molecular Biology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "The University of Heidelberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Heidelberg,"

Phrase: "D6900 Germany ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ABSTRACT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "The processing of amyloid precursor protein (APP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "production of A4 amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "are"

Phrase: "events likely to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332148:Likely [Qualitative Concept]
   827   C0441471:Events [Event]
   827   C0750492:Likely [Idea or Concept]
   827   C3541888:Events [Classification]

Phrase: "influence"

Phrase: "the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "progression of Alzheimer's disease,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0242656:Disease Progression [Pathologic Function]
           progression
   819   C1947900:Disease progression NOS [Finding]
   770   C0449258:Progression [Functional Concept]

Phrase: "since"

Phrase: "A4"

Phrase: "is"

Phrase: "the major constituent of amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0729650:constituent [Substance]

Phrase: "deposited in this disorder."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012634:Disorder [Disease or Syndrome]
   770   C0333562:deposited [Functional Concept]
Processing 00000000.tx.5: Our previous studies showed that human platelets contain full-length APP (APP) and are a suitable substrate to study normal APP processing. 

Phrase: "Our previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that human platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "a suitable substrate to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "normal APP processing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0033666:protein processing [Molecular Function]
   804   C1709694:Processing [Activity]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C0860902:normal protein [Finding]
Processing 00000000.tx.6: In the present study, we show that a 22-kDa A4-containing carboxyl-terminal fragment (22-CTF) of APP is present in unstimulated platelets. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a 22-kDa A4-containing carboxyl-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0332255:fragment [Functional Concept]
   795   C1708096:Fragment [Qualitative Concept]

Phrase: "(22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "present in unstimulated platelets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.7: Both APP and 22-CTF are proteolytically degraded when platelets are activated with thrombin, collagen, or calcium ionophore A23187. 

Phrase: "Both APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "proteolytically"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "when"

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "are"

Phrase: "activated with thrombin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "collagen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "or"

Phrase: "calcium ionophore A23187."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0878412:A23187 [Antibiotic,Organic Chemical]
   734   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.8: Complete cleavage of APP and 22-CTF require the presence of extracellular calcium. 

Phrase: "Complete cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "require"

Phrase: "the presence of extracellular calcium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.9: Following stimulation in the presence of calcium, a new CTF of 17 kDa is generated, and the NH-terminal epitope of A4 amyloid is lost. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "stimulation in the presence of calcium,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "a new CTF of 17 kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ","

Phrase: "and"

Phrase: "the NH-terminal epitope of A4 amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003316:Epitope [Immunologic Factor]

Phrase: "is"

Phrase: "lost."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]
Processing 00000000.tx.10: Preincubation of platelets with the cell-permeable cysteine protease inhibitors calpeptin, (2S,3S)-trans-epoxysuccinyl-L-leucyl-amido-3-methylbutane ethyl ester (E64d), Na-p-tosyl-L-lysine chloromethyl ketone, or calcium chelator EGTA before platelet stimulation inhibits the degradation of both APP and 22-CTF. 

Phrase: "Preincubation of platelets"

Phrase: "with the cell-permeable cysteine protease inhibitors calpeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(2S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552116:2s [Body Part, Organ, or Organ Component]

Phrase: "3S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552117:3s [Body Part, Organ, or Organ Component]

Phrase: ")-"

Phrase: "trans-epoxysuccinyl-L-leucyl-amido-3-methylbutane ethyl ester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0014898:Ester [Organic Chemical]

Phrase: "(E64d"

Phrase: ")"

Phrase: ","

Phrase: "Na-p-tosyl-L-lysine chloromethyl ketone,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0022634:Ketone [Organic Chemical]

Phrase: "or"

Phrase: "calcium chelator EGTA before platelet stimulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the degradation of both APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1327161:amyloid precursor protein degradation [Molecular Function]
   774   C0597297:Protein Degradation [Molecular Function]
   774   C0597304:Protein Degradation [Molecular Function]
   774   C1623036:Protein Degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "22-CTF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.11: Divalent metal ions including zinc, copper, and cobalt inhibit the degradation of APP and 22-CTF. 

Phrase: "Divalent metal ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022023:Ions [Element, Ion, or Isotope]
   793 E C1700702:ION [Functional Concept]
   734   C0596455:divalent metal [Element, Ion, or Isotope]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "zinc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "copper,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "cobalt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009148:Cobalt [Element, Ion, or Isotope]
  1000   C2348262:Cobalt [Element, Ion, or Isotope]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the degradation of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   864   C1327161:amyloid precursor protein degradation [Molecular Function]
   783   C0597297:Protein Degradation [Molecular Function]
   783   C0597304:Protein Degradation [Molecular Function]
   783   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "22-CTF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.12: This study suggests that a calcium-dependent neutral cysteine protease is involved in the proteolytic processing of an amyloidogenic species of APP in human platelets. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a calcium-dependent neutral cysteine protease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   933   C0006784:Calcium-Dependent Neutral Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1947941:Protease [Enzyme]

Phrase: "is"

Phrase: "involved in the proteolytic processing of an amyloidogenic species of APP"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   766   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   766   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   750   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1514570:Proteolytic Processing [Molecular Function]
   749   C0033666:protein processing [Molecular Function]
   749   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   735   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0011560:Amyloid [Pathologic Function]
   735   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0597304:Proteolytic [Molecular Function]
   735   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C1314939:Involved [Functional Concept]
   735   C1705920:Species [Conceptual Entity]
   735   C1709634:Precursor [Idea or Concept]
   735   C1709694:Processing [Activity]
   735   C1947941:proteolytic [Enzyme]

Phrase: "in human platelets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]
Processing 00000000.tx.13: INTRODUCTION The major constituent protein (A4) of amyloid plaques, which are a pathologic hallmark of Alzheimer's disease, is proteolytically derived from a larger glycoprotein precursor, the amyloid precursor protein (APP).() The A4 amyloidogenic region spans 39-44 residues, the carboxyl-terminal third of which is part of the transmembrane domain of APP (Kang et al., 1987). 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "The major constituent protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A4"

Phrase: ")"

Phrase: "of amyloid plaques,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "which"

Phrase: "are"

Phrase: "a pathologic hallmark of Alzheimer's disease,"

Phrase: "is"

Phrase: "proteolytically"

Phrase: "derived from a larger glycoprotein precursor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   753   C0443228:larger [Quantitative Concept]
   753   C0549177:Larger [Quantitative Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C1704243:Larger [Quantitative Concept]
   753   C1709634:Precursor [Idea or Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "the amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")."

Phrase: "("

Phrase: ")"

Phrase: "The A4 amyloidogenic region spans 39-44 residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1709915:Residue [Conceptual Entity]
   762   C1882936:RESIDUE [Phenomenon or Process]
   712 E C1609982:Residual [Qualitative Concept]

Phrase: "the carboxyl-terminal third of which"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205088:Terminal [Temporal Concept]
   753   C0205437:Third [Quantitative Concept]
   753   C0596260:Carboxyl [Organic Chemical]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]

Phrase: "is"

Phrase: "part of the transmembrane domain of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1292711:Part of [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]

Phrase: "(Kang et al.,"

Phrase: "1987"

Phrase: ")."
Processing 00000000.tx.14: A closely related family of membrane proteins (APLP1 and APLP2) (Sprecher et al., 1993; Wasco et al., 1992) do not contain this amyloidogenic A4 sequence. 

Phrase: "A closely related family of membrane proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0015576:Family [Family Group]
   748   C1704727:Family [Conceptual Entity]
   738   C0015608:Family Relations [Social Behavior]
   738   C0015609:family relations [Social Behavior]

Phrase: "(APLP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412466:APLP1 [Gene or Genome]

Phrase: "and"

Phrase: "APLP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: ")"

Phrase: "(Sprecher et al.,"

Phrase: "1993"

Phrase: "; Wasco et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "this amyloidogenic A4 sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.15: The family of APP glycoproteins now extends to at least 10 isoforms generated by alternate splicing of the APP gene, principally of exons 7, 8, and 15. 

Phrase: "The family of APP glycoproteins now"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0015576:Family [Family Group]
   744   C1704727:Family [Conceptual Entity]

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "to at least 10 isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   760   C1883351:To [Qualitative Concept]

Phrase: "generated by alternate splicing of the APP gene,"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0002345:Alternate Splicing [Genetic Function]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0017365:gene splicing [Gene or Genome]
   757   C0017387:Gene Splicing [Molecular Biology Research Technique]
   757   C0376437:Protein Splicing [Genetic Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0017337:Gene [Gene or Genome]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0035687:Splicing [Genetic Function]
   739   C0332270:alternate [Functional Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1523987:Alternate [Conceptual Entity]
   739   C1709634:Precursor [Idea or Concept]
   739   C2610186:splicing [Genetic Function]
   739   C3146294:Generated [Activity]

Phrase: "principally of exons 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "8,"

Phrase: "and"

Phrase: "15."
Processing 00000000.tx.16: APP, the prototypic isoform (Kang et al., 1987) is predominantly expressed in the brain, and lacks a Kunitz-type protease inhibitor domain encoded by exon 7. 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "the prototypic isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "(Kang et al.,"

Phrase: "1987"

Phrase: ")"

Phrase: "is"

Phrase: "predominantly"

Phrase: "expressed in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "a Kunitz-type protease inhibitor domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1514524:Protease Domain [Amino Acid Sequence]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "encoded by exon 7."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0679058:encoded [Mental Process]
   770   C2700640:Encoded [Activity]
Processing 00000000.tx.17: The Kunitz-type protease inhibitor domain (Kitaguchi et al., 1988; Ponte et al., 1988; Tanzi et al., 1988) is of particular interest since it might function in an autoregulatory manner by controlling proteolytic events near the cell membrane. 

Phrase: "The Kunitz-type protease inhibitor domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1514524:Protease Domain [Amino Acid Sequence]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "(Kitaguchi et al.,"

Phrase: "1988"

Phrase: "; Ponte et al.,"

Phrase: "1988"

Phrase: "; Tanzi et al.,"

Phrase: "1988"

Phrase: ")"

Phrase: "is of particular interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "since"

Phrase: "it"

Phrase: "might"

Phrase: "function in an autoregulatory manner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "by controlling proteolytic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "near the cell membrane."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0007603:Cell Membrane [Cell Component]
  1000   C3161472:Cell Membrane [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1706182:Membrane [Manufactured Object]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.18: The exclusion of exon 15 through alternate mRNA splicing generates a series of APP molecules (L-APP), which were originally discovered in cells of the lymphocyte/monocyte lineage (Knig et al., 1992). 

Phrase: "The exclusion of exon 15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]

Phrase: "through alternate mRNA splicing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0002345:Alternate Splicing [Genetic Function]
   901   C0086934:mRNA splicing [Genetic Function]
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "generates"

Phrase: "a series of APP molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205549:Series [Quantitative Concept]
   748   C2348044:Series [Intellectual Product]

Phrase: "(L-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "were"

Phrase: "originally"

Phrase: "discovered in cells of the lymphocyte/monocyte lineage"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   750   C0282637:Cell Lineage [Idea or Concept]
   744   C0007634:Cells [Cell]
   744   C0024264:Lymphocyte [Cell]
   744   C0026473:Monocyte [Cell]
   744   C1881379:Lineage [Conceptual Entity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711   C1880355:Discover [Activity]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(Knig et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.19: Subsequent studies have shown that the L-APP isoforms are predominantly expressed in non-neuronal cells, where the absence of the exon 15 domain might also be expected to influence events relating to juxta-membranous domains of APP (Sandbrink et al., 1994). 

Phrase: "Subsequent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the L-APP isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "are"

Phrase: "predominantly"

Phrase: "expressed in non-neuronal cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   851   C0027836:Non-neuronal cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1518422:Non [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "where"

Phrase: "the absence of the exon 15 domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "relating to juxta-membranous domains of APP"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0162808:Protein Domains [Spatial Concept]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   745 E C1514562:Protein Domain [Amino Acid Sequence]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0025255:Membranous [Tissue]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205117:Juxta- [Spatial Concept]
   742   C0205287:Membranous [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   720   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0163712:Relate [Organic Chemical]
   708   C1880389:Domain [Functional Concept]
   708   C1883221:Domain [Conceptual Entity]
   708   C3541951:Domain [Intellectual Product]

Phrase: "(Sandbrink et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.20: The mechanism of proteolytic processing of APP is an important problem in the study of Alzheimer's disease, since mutations in the APP gene are etiologically linked to some familial forms of the disease (Ashall and Goate, 1994). 

Phrase: "The mechanism of proteolytic processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "an important problem in the study of Alzheimer's disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0033213:Problem [Finding]

Phrase: "since"

Phrase: "mutations in the APP gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "etiologically"

Phrase: "linked to some familial forms of the disease"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   767   C0277558:Familial disease [Disease or Syndrome]
   754   C1832428:Familial form [Finding]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0015576:familial [Family Group]
   744   C0241888:Familial [Functional Concept]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   731 E C0344339:disease family [Finding]
   711   C1517892:Link [Intellectual Product]
   711 E C1522492:Form [Functional Concept]
   711   C1704666:Link [Intellectual Product]

Phrase: "(Ashall"

Phrase: "and"

Phrase: "Goate,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.21: The pathogenic mutations occur at or near the cleavage sites involved in the release of the A4 protein. 

Phrase: "The pathogenic mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "occur at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1709305:Occur [Activity]
   833   C2745955:OCCUR [Temporal Concept]

Phrase: "or near the cleavage sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0010813:cleavage [Cell Function]
   760   C0205145:Sites [Spatial Concept]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "involved in the release of the A4 protein."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0030685:Release [Health Care Activity]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.22: Mutations near the NH terminus (-secretase site) and near the -secretase site of A4 cause increased secretion of A4 in transfected cells (Cai et al., 1993; Citron et al., 1992; Haass et al., 1994). 

Phrase: "Mutations near the NH terminus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(-secretase site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "and near the -secretase site of A4 cause increased secretion of A4"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C2945843:Site of [Qualitative Concept]
   736   C0015127:cause [Functional Concept]
   736   C0036536:secretion [Biologic Function]
   736   C0036537:Secretion [Body Substance]
   736   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0205145:Site [Spatial Concept]
   736   C0205217:Increased [Quantitative Concept]
   736   C0442805:Increased [Functional Concept]
   736   C1515974:Site [Body Location or Region]
   736   C1515981:And [Idea or Concept]
   736   C1524003:Cause [Conceptual Entity]
   736   C2825164:Site [Spatial Concept]

Phrase: "in transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Cai et al.,"

Phrase: "1993"

Phrase: "; Citron et al.,"

Phrase: "1992"

Phrase: "; Haass et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.23: Mutations just outside the COOH-terminal -secretase site of A4 (codon 717) cause an increase in the ratio of A4 to A4 (Suzuki et al., 1994). 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "just outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205101:Outside [Spatial Concept]

Phrase: "the COOH-terminal -secretase site of A4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "(codon 717"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: ")"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in the ratio of A4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "to A4"

Phrase: "(Suzuki et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.24: Longer A4 (A4) shows a greater tendency to aggregate. 

Phrase: "Longer A4"

Phrase: "(A4"

Phrase: ")"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a greater tendency to"

Phrase: "aggregate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.25: However, the molecular mechanisms of A4 deposition and accumulation in the more common sporadic forms of the disease are not well understood. 

Phrase: "However,"

Phrase: "the molecular mechanisms of A4 deposition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "accumulation in the more common sporadic forms of the disease"

Phrase: "are"

Phrase: "not well understood."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   793   C0162340:Understand [Mental Process]
Processing 00000000.tx.26: APP is modified post-translationally by different proteolytic pathways. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "post-translationally by different proteolytic pathways."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0597304:Proteolytic [Molecular Function]
   753   C0687676:Post [Temporal Concept]
   753   C1704259:Pathways [Molecular Function]
   753   C1704687:Post [Manufactured Object]
   753   C1705242:Different [Qualitative Concept]
   753   C1705987:Pathways [Conceptual Entity]
   753   C1947941:proteolytic [Enzyme]
Processing 00000000.tx.27: Most studies of APP metabolism have been carried out in cell lines transfected with APP or APP cDNA and show that about 15-30% of the newly synthesized full-length APP (APP) passes through a constitutive secretory pathway. 

Phrase: "Most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "studies of APP metabolism"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   882   C1327340:amyloid precursor protein metabolism [Molecular Function]
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0597299:Protein Metabolism [Molecular Function]
   783   C0280606:metabolism studies [Diagnostic Procedure]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0557651:Study [Manufactured Object]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0947630:studies [Laboratory Procedure]
   753   C1709634:Precursor [Idea or Concept]
   753   C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0007600:Cell lines [Cell]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "transfected with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "APP cDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that about 15-30% of the newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0750546:newly [Idea or Concept]

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "passes through a constitutive secretory pathway."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1159343:constitutive secretory pathway [Cell Function]
   790   C1159342:Secretory Pathway [Cell Function]
   753   C1327616:Secretory [Cell Function]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C2828386:Pass [Finding]
Processing 00000000.tx.28: This generates the release of a large NH-terminal extracellular fragment of 100-130 kDa into the extracellular compartment and an approximately 10-kDa membrane-associated COOH-terminal fragment (CTF) (Knops et al., 1992; Kuentzel et al., 1993; Weidemann et al., 1989). 

Phrase: "This"

Phrase: "generates"

Phrase: "the release of a large NH-terminal extracellular fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of 100-130 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "into the extracellular compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "and"

Phrase: "an approximately 10-kDa membrane-associated COOH-terminal fragment (CTF)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0332255:fragment [Functional Concept]
   793   C1708096:Fragment [Qualitative Concept]

Phrase: "(Knops et al.,"

Phrase: "1992"

Phrase: "; Kuentzel et al.,"

Phrase: "1993"

Phrase: "; Weidemann et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.29: This process involves cleavage in the middle of the A4 sequence by a putative -secretase activity and therefore precludes formation of intact A4 peptide (Esch et al., 1990; Sisodia et al., 1990). 

Phrase: "This process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "involves"

Phrase: "cleavage in the middle of the A4 sequence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "by a putative -secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "precludes"

Phrase: "formation of intact A4 peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1327133:peptide formation [Molecular Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(Esch et al.,"

Phrase: "1990"

Phrase: "; Sisodia et al.,"

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.30: Some of the remaining APP may be reinternalized from the cell surface and degraded in a lysosome/endosome compartment to generate a family of 8-22-kDa CTFs (Golde et al., 1992; Haass et al., 1992; Knops et al., 1992). 

Phrase: "Some of the remaining APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205392:Some [Quantitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1527428:Remaining [Qualitative Concept]
   748   C1709634:Precursor [Idea or Concept]
   748   C3540770:Some [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "reinternalized from the cell surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "degraded in a lysosome/endosome compartment to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0024369:Lysosome [Cell Component]
   748   C0034850:Endosome [Cell Component]
   748   C1185625:Compartment [Body Space or Junction]
   748   C1881707:DEGRADED [Phenomenon or Process]
   748   C2984253:Lysosome [Functional Concept]
   748   C2986730:Compartment [Spatial Concept]

Phrase: "generate"

Phrase: "a family of 8-22-kDa CTFs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015576:Family [Family Group]
   748   C1704727:Family [Conceptual Entity]

Phrase: "(Golde et al.,"

Phrase: "1992"

Phrase: "; Haass et al.,"

Phrase: "1992"

Phrase: "; Knops et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.31: In addition, low levels of intact A4 or A4 are normally secreted by cells in culture (Cai et al., 1993; Haass et al., 1993; Seubert et al., 1993; Suzuki et al., 1994). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "low levels of intact A4"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "A4"

Phrase: "are"

Phrase: "normally"

Phrase: "secreted by cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1327616:Secreted [Cell Function]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "(Cai et al.,"

Phrase: "1993"

Phrase: "; Haass et al.,"

Phrase: "1993"

Phrase: "; Seubert et al.,"

Phrase: "1993"

Phrase: "; Suzuki et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.32: This processing may occur either at an early step of the endosomal-lysosomal pathway following endocytosis (Koo and Squazzo, 1994; Shoji et al., 1992), or in a late acidic compartment of the secretory pathway (Busciglio et al., 1993). 

Phrase: "This processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "may"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "either at an early step of the endosomal-lysosomal pathway"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0521450:Lysosomal [Body Location or Region]
   739   C1261552:Step [Conceptual Entity]
   739   C1279919:Early [Temporal Concept]
   739   C1704259:Pathway [Molecular Function]
   739   C1704379:Step [Functional Concept]
   739   C1705117:Step [Quantitative Concept]
   739   C1705987:Pathway [Conceptual Entity]
   739   C2825408:Step [Manufactured Object]
   722   C0887883:Early endosome [Cell Component]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "(Koo"

Phrase: "and"

Phrase: "Squazzo,"

Phrase: "1994"

Phrase: "; Shoji et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "or in a late acidic compartment of the secretory pathway"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C1159342:Secretory Pathway [Cell Function]
   739   C0001128:Acidic [Chemical]
   739   C0205087:Late [Temporal Concept]
   739   C1185625:Compartment [Body Space or Junction]
   739   C1327616:Secretory [Cell Function]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]
   739   C2986730:Compartment [Spatial Concept]

Phrase: "(Busciglio et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.33: Proteases termed - and -secretases are required to produce the NH- and COOH termini of A4, respectively. 

Phrase: "Proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "-"

Phrase: "and -"

Phrase: "secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "the NH-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: "and"

Phrase: "COOH termini of A4,"

Phrase: "respectively."
Processing 00000000.tx.34: -Secretase activity is either integrated into the cell membrane or operates after release of the transmembrane domain of APP from the membrane. 

Phrase: "-Secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "either"

Phrase: "integrated into the cell membrane"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0007603:Cell Membrane [Cell Component]
   806   C3161472:Cell Membrane [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1706182:Membrane [Manufactured Object]
   760   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "operates after release of the transmembrane domain of APP"
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1519623:Transmembrane Domain [Amino Acid Sequence]
   754   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   754   C0162808:Protein Domain [Spatial Concept]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C1514562:Protein Domain [Amino Acid Sequence]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0030685:Release [Health Care Activity]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0391871:Release [Functional Concept]
   738   C0439180:% release [Quantitative Concept]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0680255:release [Health Care Activity]
   738   C1167322:transmembrane [Cell Component]
   738   C1283071:Release [Functional Concept]
   738   C1709634:Precursor [Idea or Concept]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C1963578:Release [Therapeutic or Preventive Procedure]
   738   C2752508:transmembrane [Cell Component]
   738   C3242339:operate [Functional Concept]
   738   C3541951:Domain [Intellectual Product]

Phrase: "from the membrane."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.35: Numerous proteases have been implicated in APP processing (reviewed by Evin et al.(1994)). 

Phrase: "Numerous proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in APP processing"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033666:protein processing [Molecular Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
   753   C1709694:Processing [Activity]

Phrase: "("

Phrase: "reviewed by Evin et al.(1994"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0282443:reviewed [Intellectual Product]
   753   C1709940:Reviewed [Qualitative Concept]
   719 E C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.36: The proteases which cleave APP in vivo have not been identified. 

Phrase: "The proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "which"

Phrase: "cleave"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.37: On the basis of specificity and amino acid sequence alone, it is difficult to predict which proteases are important for APP cleavage in vivo because some proteases may require a specific secondary or tertiary conformation of the substrate (Sisodia, 1992). 

Phrase: "On the basis of specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "amino acid sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "predict"

Phrase: "which proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "are"

Phrase: "important for APP cleavage"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "because"

Phrase: "some proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "may"

Phrase: "require"

Phrase: "a specific secondary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]

Phrase: "or"

Phrase: "tertiary conformation of the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026377:Conformation [Spatial Concept]

Phrase: "(Sisodia,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.38: Alternatively, the subcellular compartmentation of many proteases may exclude them from action on APP. 

Phrase: "Alternatively,"

Phrase: "the subcellular compartmentation of many proteases"

Phrase: "may"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "them from action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0441472:Action [Functional Concept]
   790   C3266814:Action [Activity]

Phrase: "on APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.39: For this reason, it is important to study APP processing in a cellular system where normal compartmentation is preserved. 

Phrase: "For this reason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "APP processing in a cellular system where normal compartmentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0033666:protein processing [Molecular Function]
   738   C1709694:Processing [Activity]

Phrase: "is"

Phrase: "preserved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033085:Preserved [Laboratory Procedure]
Processing 00000000.tx.40: We have demonstrated that human platelets contain APP (Li et al., 1994). 

Phrase: "We"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that human platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(Li et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.41: Therefore platelets may be a useful model to study normal APP processing. 

Phrase: "Therefore platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "a useful model to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "normal APP processing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0033666:protein processing [Molecular Function]
   804   C1709694:Processing [Activity]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C0860902:normal protein [Finding]
Processing 00000000.tx.42: Unlike transfected cell lines in which the processing of APP may not totally reflect processing in vivo (Zhong et al., 1994), purified platelets provide a model system which may be closer to that which occurs in vivo. 

Phrase: "Unlike transfected cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "in which"

Phrase: "the processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "may"

Phrase: "not totally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "processing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]
   966 E C1522240:Process [Phenomenon or Process]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Zhong et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "purified platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a model system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0026339:Model System [Intellectual Product,Research Device]
  1000   C3161035:Model System [Intellectual Product]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "closer to that"

Phrase: "which"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.43: Platelets are the main source of hematogenous APP and platelet APP is readily released upon physiological stimulation (Bush et al., 1990; Cole et al., 1990; Smith and Broze, 1992; Van Nostrand et al., 1991). 

Phrase: "Platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "are"

Phrase: "the main source of hematogenous APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449416:Source [Finding]
   744   C1705919:Source [Idea or Concept]

Phrase: "and"

Phrase: "platelet APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C0582509:platelet precursor [Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "readily"

Phrase: "released upon physiological stimulation"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0205463:Physiological [Functional Concept]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(Bush et al.,"

Phrase: "1990"

Phrase: "; Cole et al.,"

Phrase: "1990"

Phrase: "; Smith"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "and"

Phrase: "Broze,"

Phrase: "1992"

Phrase: "; Van Nostrand et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.44: The released APP potently inhibits coagulation factor XIa (Smith et al., 1990), suggesting a role for APP in hemostasis. 

Phrase: "The released APP potently"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "coagulation factor XIa"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015524:Coagulation Factor XIa [Amino Acid, Peptide, or Protein,Enzyme]
           Factor XIa
   734   C0005789:Coagulation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Smith et al.,"

Phrase: "1990"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role for APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in hemostasis."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0019116:Haemostasis [Organ or Tissue Function]
  1000   C0740166:Haemostasis [Therapeutic or Preventive Procedure]
   928 E C0019120:Haemostatic [Pharmacologic Substance]
   900 E C0180950:Haemostat [Medical Device]
Processing 00000000.tx.45: In the present study, we investigated the processing of APP in stimulated platelets. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "in stimulated platelets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]
Processing 00000000.tx.46: We describe the identification and degradation of a A4-containing 22-kDa CTF of APP following platelet activation. 

Phrase: "We"

Phrase: "describe"

Phrase: "the identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "degradation of a A4-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "22-kDa CTF of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "platelet activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032173:Platelet Activation [Organ or Tissue Function]
   861   C1879547:Activation [Activity]
Processing 00000000.tx.47: Our data suggest that a calcium-dependent neutral cysteine protease is involved in the degradation of the amyloidogenic species of APP in platelets. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a calcium-dependent neutral cysteine protease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   933   C0006784:Calcium-Dependent Neutral Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1947941:Protease [Enzyme]

Phrase: "is"

Phrase: "involved in the degradation of the amyloidogenic species of APP"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   785   C1327161:amyloid precursor protein degradation [Molecular Function]
   770   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   770   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   753   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0597297:Protein Degradation [Molecular Function]
   751   C0597304:Protein Degradation [Molecular Function]
   751   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C1623036:Protein Degradation [Molecular Function]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0243125:degradation [Functional Concept]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0699900:Degradation [Organism Function]
   736   C1314939:Involved [Functional Concept]
   736   C1705920:Species [Conceptual Entity]
   736   C1709634:Precursor [Idea or Concept]

Phrase: "in platelets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]
Processing 00000000.tx.48: EXPERIMENTAL PROCEDURES Materials Calpeptin was obtained from Calbiochem-Novabiochem Pty. 

Phrase: "EXPERIMENTAL PROCEDURES Materials Calpeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "obtained from Calbiochem-Novabiochem Pty."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.49: (Alexandria, Australia) and dissolved in dimethyl sulfoxide. 

Phrase: "(Alexandria,"

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "dissolved in dimethyl sulfoxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   770   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0038771:sulfoxide [Organic Chemical]
   770   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   737   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.50: Rainbow protein molecular weight markers were purchased from Amersham Corp. 

Phrase: "Rainbow protein molecular weight markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0005516:molecular markers [Clinical Attribute]
           Marker

Phrase: "were"

Phrase: "purchased from Amersham Corp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0683758:Corp. [Organization]
   770   C0869011:purchased [Activity]
Processing 00000000.tx.51: (Aylesbury, United Kingdom). 

Phrase: "(Aylesbury,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.52: Electrophoresis-grade acrylamide, N,N`-methylene bisacrylamide, N,N,N`,N`-tetramethylethylenediamine, and ammonium persulfate were obtained from Bio-Rad. 

Phrase: "Electrophoresis-grade acrylamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "N,N`-methylene bisacrylamide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0067314:N,N'-methylenebisacrylamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           methylene bisacrylamide
   812   C0054666:methylene [Organic Chemical,Pharmacologic Substance]

Phrase: "N,N,N`,N`-tetramethylethylenediamine,"

Phrase: "and"

Phrase: "ammonium persulfate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051723:Ammonium persulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   861   C2726663:PERSULFATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Bio-Rad."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.53: Purified calpain I and II were purchased from Nacalai Tesque, Inc. 

Phrase: "Purified calpain I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II"

Phrase: "were"

Phrase: "purchased from Nacalai Tesque,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.54: (Kyoto, Japan). 

Phrase: "(Kyoto,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.55: Leupeptin was from Auspep (West Melbourne, Australia). 

Phrase: "Leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was from Auspep"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "(West Melbourne,"

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")."
Processing 00000000.tx.56: PGE, collagen, calcium ionophore A23187, phorbol 12-myristate 13-acetate (PMA), trans-epoxysuccinyl-L-leucylamido-(4-guanidino)-butane (E64), (2S,3S)-trans-epoxysuccinyl-L-leucyl-amido-3-methylbutane ethyl ester (E64d), Na-p-tosyl-L-lysine chloromethyl ketone (TLCK), N-tosyl-L-phenylalanine chloromethyl ketone (TPCK), diisopropyl fluorophosphate (DFP), 1,10-phenanthroline, phosphoramidon, phenylmethylsulfonyl fluoride (PMSF), iodoacetamide, and EGTA were from Sigma. 

Phrase: "PGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033559:PGE [Biologically Active Substance,Eicosanoid]

Phrase: "collagen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "calcium ionophore A23187,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0878412:A23187 [Antibiotic,Organic Chemical]
   734   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "phorbol 12-myristate 13-acetate (PMA),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: "trans-epoxysuccinyl-L-leucylamido-"

Phrase: "(4-guanidino"

Phrase: ")-"

Phrase: "butane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006474:Butane [Organic Chemical,Pharmacologic Substance]
  1000   C0006476:butane [Organic Chemical]

Phrase: "(E64"

Phrase: ")"

Phrase: ","

Phrase: "(2S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552116:2s [Body Part, Organ, or Organ Component]

Phrase: "3S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552117:3s [Body Part, Organ, or Organ Component]

Phrase: ")-"

Phrase: "trans-epoxysuccinyl-L-leucyl-amido-3-methylbutane ethyl ester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0014898:Ester [Organic Chemical]

Phrase: "(E64d"

Phrase: ")"

Phrase: ","

Phrase: "Na-p-tosyl-L-lysine chloromethyl ketone (TLCK),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0022634:Ketone [Organic Chemical]

Phrase: "N-tosyl-L-phenylalanine chloromethyl ketone (TPCK),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0022634:Ketone [Organic Chemical]

Phrase: "diisopropyl fluorophosphate (DFP),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022181:Diisopropyl fluorophosphate [Hazardous or Poisonous Substance,Organophosphorus Compound,Pharmacologic Substance]
   861   C0060567:fluorophosphate [Inorganic Chemical]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "phenylmethylsulfonyl fluoride (PMSF),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "iodoacetamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "were from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.57: Thrombin was from Boehringer Mannheim (Mannheim, Germany). 

Phrase: "Thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "was from Boehringer Mannheim"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "(Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.58: Protein A-Sepharose CL-4B was purchased from Pharmacia LKB (Uppsala, Sweden). 

Phrase: "Protein A-Sepharose CL-4B"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0074345:Sepharose CL 4B [Carbohydrate]
   853   C0036682:Sepharose 4B [Biomedical or Dental Material,Carbohydrate]
   804   C0450375:4b [Intellectual Product]
   717   C0075172:protein A-sepharose [Carbohydrate]

Phrase: "was"

Phrase: "purchased from Pharmacia LKB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0331955:Pharmacia [Health Care Related Organization]
   770   C0869011:purchased [Activity]

Phrase: "(Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")."
Processing 00000000.tx.59: Protein concentrations were determined by the BCA method (Pierce, Rockford, IL). 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined by the BCA method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C1332420:bca [Gene or Genome]

Phrase: "(Pierce,"

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.60: Immobilon P (PVDF) was from Millipore Corp. 

Phrase: "Immobilon P (PVDF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0071710:PVDF [Organic Chemical]
   734   C0123400:Immobilon P [Organic Chemical]

Phrase: ")"

Phrase: "was from Millipore Corp."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0683758:Corp. [Organization]
   770   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.61: (Bedford, MA). 

Phrase: "(Bedford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.62: All other chemicals were of analytical reagent grade. 

Phrase: "All"

Phrase: "other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were of analytical reagent grade."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   760   C0441800:Grade [Classification]
   760   C0919553:Grade [Classification]
   760   C0936012:Analytical [Research Activity]
   760   C3244287:grade [Finding]
Processing 00000000.tx.63: Antibodies Monoclonal antibody (mAb) 22C11, which recognizes an epitope near the amino terminus of APP (Weidemann et al., 1989; Hilbich et al., 1993), was from Boehringer Mannheim GmbH (Germany). 

Phrase: "Antibodies Monoclonal antibody (mAb) 22C11,"

Phrase: "which"

Phrase: "recognizes"

Phrase: "an epitope near the amino terminus of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0003316:Epitope [Immunologic Factor]

Phrase: "(Weidemann et al.,"

Phrase: "1989"

Phrase: "; Hilbich et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: ","

Phrase: "was from Boehringer Mannheim GmbH (Germany"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017480:Germany [Geographic Area]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1421478:WAS [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.64: Polyclonal rabbit antibody 92/9 was raised against purified human APP (Moir et al., 1992). 

Phrase: "Polyclonal rabbit antibody 92/9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0034493:Rabbit [Mammal]

Phrase: "was"

Phrase: "raised against purified human APP"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086418:Human [Human]
   748   C0442818:Raised [Quantitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
   748   C1998793:Purified [Functional Concept]

Phrase: "(Moir et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.65: Affinity-purified rabbit antibody to the cytoplasmic domain (residues 645-694) of APP (Ab 369A) (Buxbaum et al., 1990; Nordstedt et al., 1991) was kindly provided by Dr. 

Phrase: "Affinity-purified rabbit antibody to the cytoplasmic domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0003255:Antibody Affinity [Molecular Function]
   767   C0312620:Cytoplasmic antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(residues 645-694"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(Ab 369A"

Phrase: ")"

Phrase: "(Buxbaum et al.,"

Phrase: "1990"

Phrase: "; Nordstedt et al.,"

Phrase: "1991"

Phrase: ")"

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.66: Sam Gandy (Cornell University Medical College, New York). 

Phrase: "Sam Gandy (Cornell University Medical College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0557806:College [Manufactured Object]

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.67: An anti-CT antibody (raised to 704-730 of APP) was a gift from Dr. 

Phrase: "An anti-CT antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "raised to 704-730 of APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0442818:Raised [Quantitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "a gift from Dr."
Processing 00000000.tx.68: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.69: Cordell (Scios Nova Inc., Mountain View, CA). 

Phrase: "Cordell"

Phrase: "(Scios Nova Inc.,"

Phrase: "Mountain View,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "CA)."
Processing 00000000.tx.70: Monoclonal 6E10 which recognizes residues 1-17 of A4 (Kim et al., 1990) was purchased from the New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY. 

Phrase: "Monoclonal 6E10"

Phrase: "which"

Phrase: "recognizes"

Phrase: "residues 1-17 of A4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(Kim et al.,"

Phrase: "1990"

Phrase: ")"

Phrase: "was"

Phrase: "purchased from the New York State Institute"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0027976:New York [Geographic Area]
   748   C0021622:institute [Organization]
   748   C0205314:New [Temporal Concept]
   748   C0869011:purchased [Activity]
   748   C1272753:Institute [Idea or Concept]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]

Phrase: "for Basic Research"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0681833:Basic Research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "in Developmental Disabilities,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0008073:Developmental Disabilities [Mental or Behavioral Dysfunction]
  1000   C1552527:Developmental Disabilities [Health Care Related Organization,Manufactured Object]
   861   C0231170:Disabilities [Finding]
   861   C0458003:Developmental [Qualitative Concept]
   861   C0678723:Developmental [Organism Function]
   789 E C0243107:development [Physiologic Function]
   789 E C1527148:Development [Functional Concept]
   777 E C0018576:Disabled [Patient or Disabled Group]
   777 E C1880351:Disabled [Qualitative Concept]

Phrase: "Staten Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]
Processing 00000000.tx.71: Polyclonal antibody ``730'' was raised against residues 1-40 of A4. 

Phrase: "Polyclonal antibody ``730''"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "raised against residues 1-40 of A4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439509:/40 [Temporal Concept]
   748   C0442818:Raised [Quantitative Concept]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.72: Monoclonal antibodies to talin and thrombospondin were purchased from Sigma. 

Phrase: "Monoclonal antibodies to talin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0746619:monoclonal [Finding]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "thrombospondin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "purchased from Sigma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.73: Antibody to GPIb (WM23) has been previously characterized (Berndt et al., 1985; Li et al., 1994). 

Phrase: "Antibody to GPIb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(WM23"

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "(Berndt et al.,"

Phrase: "1985"

Phrase: "; Li et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.74: Affinity purified anti-mouse and anti-rabbit alkaline phosphatase-conjugated secondary antibodies were obtained from Promega Corp. 

Phrase: "Affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "anti-rabbit alkaline phosphatase-conjugated secondary antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   893   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   876 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   860   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   762 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Promega Corp."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0072149:Promega [Lipid]
   770   C0683758:Corp. [Organization]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.75: (Madison, WI). 

Phrase: "(Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.76: Platelet Preparation and Activation Human platelets were prepared from fresh blood as described previously (Li et al., 1994). 

Phrase: "Platelet Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "Activation Human platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005821:Platelets [Cell]
   827   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "prepared from fresh blood"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0229664:Blood [Body Substance]
   770   C0443224:Fresh [Qualitative Concept]
   770   C2827486:Fresh [Body Substance]
   737   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Li et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.77: In brief, platelets were isolated by centrifugation and washed twice in buffer (0.38% sodium citrate, 0.6% glucose, 0.72% NaCl, pH 7.0) in the presence of 3 M PGE. 

Phrase: "In brief, platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "isolated by centrifugation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "(0.38% sodium citrate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   812   C0008857:Citrate [Organic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "0.6% glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "0.72% NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 7.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 3 M PGE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033559:PGE [Biologically Active Substance,Eicosanoid]
Processing 00000000.tx.78: Platelets were then resuspended (1 10/ml) in Tyrode's buffer (136.9 mM NaCl, 2.68 mM KCl, 11.9 mM NaHCO, 0.42 mM NaHPO with 2 mM CaCl, 1 mM MgCl, 5.5 mM glucose, pH 7.4) (calcium-containing medium). 

Phrase: "Platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resuspended"

Phrase: "(1 10/ml) in Tyrode's buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "(136.9 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "2.68 mM KCl,"

Phrase: "11.9 mM NaHCO,"

Phrase: "0.42 mM NaHPO with 2 mM CaCl,"

Phrase: "1 mM MgCl,"

Phrase: "5.5 mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "(calcium-containing medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: In some cases, platelets were resuspended in EHS buffer (10 mM HEPES, 150 mM NaCl, and 1 mM EDTA, pH 7.4) (calcium-free medium). 

Phrase: "In some cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "resuspended in EHS buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "(calcium-free medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0009458:Medium [Intellectual Product]
   827   C0332296:free [Functional Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.80: The platelets were then incubated with 1 M A23187, or 1 M PMA, or a combination of 1 unit/ml thrombin and 20 g/ml collagen for 15 min at room temperature with stirring in the presence of calcium (Tyrode's buffer), unless indicated. 

Phrase: "The platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with 1 M A23187,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0878412:A23187 [Antibiotic,Organic Chemical]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "1 M PMA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   863   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   795   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "a combination of 1 unit/ml thrombin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205195:Combination [Qualitative Concept]
   748   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "20 g/ml collagen for 15 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   748   C1167364:collagen [Cell Component]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with stirring"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(Tyrode's buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "unless"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.81: After the incubation, EGTA (200 mM, pH 9.0) was added to a final concentration of 5 mM just before centrifugation to separate the platelets from the incubation medium. 

Phrase: "After the incubation,"

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(200 mM,"

Phrase: "pH 9.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "added to a final concentration of 5 mM just"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0086045:Concentration [Mental Process]
   742   C0205088:Final [Temporal Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1524062:Added [Functional Concept]
   742   C1546485:Final [Idea or Concept]
   708 E C1883712:Add [Functional Concept]

Phrase: "before"

Phrase: "centrifugation to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "the platelets from the incubation medium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005821:Platelets [Cell]
   753   C1963076:Platelets [Finding]
Processing 00000000.tx.82: The platelet pellets were lysed in a modified EHS buffer containing 5 mM EDTA, 1% (v/v) Triton X-100, 0.2 mg/ml leupeptin, and 1 mM PMSF followed by brief centrifugation at 9000 g in a microcentrifuge to remove cytoskeletal elements. 

Phrase: "The platelet pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "lysed in a modified EHS buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0024348:lysed [Pathologic Function]
   753   C0392747:Modified [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(v/v) Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "0.2 mg/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "1 mM PMSF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "followed by brief centrifugation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C1282927:brief [Qualitative Concept]
   770   C1879313:Brief [Temporal Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "at 9000 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "in a microcentrifuge to"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "cytoskeletal elements."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.83: Preparation of Platelet Lysate for Calpain Digestion To obtain platelet lysate for calpain digestion, platelets were lysed in Tyrode's buffer (with 1% Triton X-100, lacking calcium and any protease inhibitors). 

Phrase: "Preparation of Platelet Lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "for Calpain Digestion To"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0012238:Digestion [Organism Function]
   827   C2349986:Digestion [Research Activity]
   771 E C0443277:Peptic [Functional Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "platelet lysate for calpain digestion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1881488:Lysate [Physical Object]

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "lysed in Tyrode's buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:lysed [Pathologic Function]

Phrase: "("

Phrase: "with 1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "and"

Phrase: "any protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.84: Digestion of the CTF of APP with calpain was performed as follows. 

Phrase: "Digestion of the CTF of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1523943:protein digestion [Organism Function]
   757   C2349986:Protein Digestion [Research Activity]
           Digestion
   739   C0012238:Digestion [Organism Function]

Phrase: "with calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.85: Calcium chloride (final concentration, 2 mM) and calpain I or II (final concentration, 20 g/ml) were added to 20 l of lysate (equivalent to 2 10 platelets) and incubated for 30 min at 30 C. 

Phrase: "Calcium chloride"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006686:Calcium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(final concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "2 mM)"

Phrase: "and"

Phrase: "calpain I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "II"

Phrase: "(final concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "20 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "added to 20 l of lysate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C1524062:Added [Functional Concept]
   753   C1881488:Lysate [Physical Object]
   719 E C1883712:Add [Functional Concept]

Phrase: "(equivalent to 2 10 platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205163:Equivalent [Qualitative Concept]
   760   C0439185:equivalent [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "incubated for 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 30 C."
Processing 00000000.tx.86: The reaction was terminated by adding sample buffer (42 mM Tris-HCl, 1% (w/v) glycine, 2% (w/v) SDS, and 5% (v/v) -mercaptoethanol). 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by adding sample buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C1553404:terminated [Idea or Concept]
   760   C2347026:Sample [Conceptual Entity]
   760   C2348570:Terminated [Functional Concept]
   726   C1883712:Add [Functional Concept]

Phrase: "(42 mM Tris-HCl,"

Phrase: "1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "glycine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: "2%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "SDS,"

Phrase: "and"

Phrase: "5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(v/v) -mercaptoethanol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025402:Mercaptoethanol [Organic Chemical]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.87: In some cases, platelet lysates were preincubated with the indicated reagents for 5 min before addition of calpain. 

Phrase: "In some cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "platelet lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "preincubated with the indicated reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   760   C1444656:Indicated [Finding]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "before addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of calpain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.88: SDS-Polyacrylamide Gel Electrophoresis (PAGE) and Western Blotting Lysate equivalent to 2 10 platelets were dissolved in sample buffer, reduced, boiled, and separated on 15 or 8.5% discontinuous polyacrylamide gels in the presence of SDS. 

Phrase: "SDS-Polyacrylamide Gel Electrophoresis (PAGE)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   923   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "Western Blotting Lysate equivalent to 2 10 platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205163:Equivalent [Qualitative Concept]
   744   C0439185:equivalent [Quantitative Concept]

Phrase: "were"

Phrase: "dissolved in sample buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]
   737   C1549535:Dissolve [Functional Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "boiled,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0242301:Boil [Disease or Syndrome]
   966   C1546559:Boil [Intellectual Product]

Phrase: "and"

Phrase: "separated on 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "or"

Phrase: "8.5% discontinuous polyacrylamide gels in the presence of SDS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   739   C0017243:Gels [Biomedical or Dental Material]
   739   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   706 E C1382104:Gel [Substance]
Processing 00000000.tx.89: The proteins were then transferred electrophoretically to Immobilon P membranes (PVDF, Millipore) as described previously (Li et al., 1994). 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "electrophoretically to Immobilon P membranes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0123400:Immobilon P [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   760   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "(PVDF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071710:PVDF [Organic Chemical]

Phrase: "Millipore"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Li et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.90: Nonspecific binding of primary antibody was blocked with 3% (w/v) bovine serum albumin and the PVDF membranes were incubated with primary antibody overnight at 4 C. 

Phrase: "Nonspecific binding of primary antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0312590:Nonspecific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0205370:Non-specific [Qualitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C0750540:Nonspecific [Idea or Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "blocked with 3%"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "the PVDF membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with primary antibody overnight"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4 C."
Processing 00000000.tx.91: Affinity-purified secondary anti-mouse or anti-rabbit IgG conjugated to alkaline phosphatase (1:10,000) were used for immunodetection of the bound primary antibody. 

Phrase: "Affinity-purified secondary anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mouse [Mammal]
   804   C0025929:mouse [Mammal]
   804   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0034493:Rabbit [Mammal]

Phrase: "conjugated to alkaline phosphatase"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0522529:Conjugated [Spatial Concept]
   770   C1149880:phosphatase [Molecular Function]
   770   C1979842:Alkaline [Qualitative Concept]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: ")"

Phrase: "were"

Phrase: "used for immunodetection of the bound primary antibody."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   750   C1524063:Use of [Functional Concept]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0205225:Primary [Qualitative Concept]
   744   C0332297:bound [Spatial Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1273517:used [Finding]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.92: The alkaline phosphatase-conjugated secondary antibody was visualized by chromogenic reaction using Fast-Red/Naphthol AS-MX phosphate as substrates for the alkaline phosphatase. 

Phrase: "The alkaline phosphatase-conjugated secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "visualized by chromogenic reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0234621:Visualized [Functional Concept]
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Fast-Red/Naphthol AS-MX phosphate as substrates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0249921:naphthol AS-MX phosphate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for the alkaline phosphatase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1149880:phosphatase [Molecular Function]
   861   C1979842:Alkaline [Qualitative Concept]
Processing 00000000.tx.93: Where indicated, chemiluminescence was used to detect the primary antibody (369A) on PVDF membrane: a horseradish peroxidase-linked secondary antibody was used and visualized by enhanced chemiluminescence (Boehringer Mannheim) according to the instructions provided by the manufacturer. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "chemiluminescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162524:Chemiluminescence [Natural Phenomenon or Process]
  1000   C1450278:Chemiluminescence [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(369A"

Phrase: ")"

Phrase: "on PVDF membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ":"

Phrase: "a horseradish peroxidase-linked secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "visualized by enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]

Phrase: "(Boehringer Mannheim"

Phrase: ")"

Phrase: "according to the instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302828:instructions [Intellectual Product]
  1000   C1442085:Instructions [Idea or Concept]
  1000   C3263700:Instructions [Clinical Attribute]
   966 E C0039401:Instruction [Educational Activity]

Phrase: "provided by the manufacturer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.94: Reproducibility of Experiments The figures and tables present representative results of experiments which were performed at least three times. 

Phrase: "Reproducibility of Experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514863:Reproducibility [Qualitative Concept]

Phrase: "The figures"

Phrase: "and"

Phrase: "tables"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: "present representative results of experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C2825142:Experimental Result [Finding]
           Result
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]

Phrase: "which"

Phrase: "were"

Phrase: "performed at least three times."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.95: RESULTS Processing of Full-length APP in Whole Platelets Previous studies have identified 140-150-kDa APP in platelets (Li et al., 1994; Gardella et al., 1992; Schlossmacher et al., 1992). 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "Processing of Full-length APP"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0033666:protein processing [Molecular Function]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443225:Full [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   748   C1709634:Precursor [Idea or Concept]
   748   C1709694:Processing [Activity]
   714 E C1184743:Process [Body Part, Organ, or Organ Component]
   714 E C1522240:Process [Phenomenon or Process]

Phrase: "in Whole Platelets Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "140-150-kDa APP in platelets"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   750   C0582509:platelet precursor [Biologically Active Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "(Li et al.,"

Phrase: "1994"

Phrase: "; Gardella et al.,"

Phrase: "1992"

Phrase: "; Schlossmacher et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.96: Processing of this species may generate amyloid-containing fragments. 

Phrase: "Processing of this species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "may"

Phrase: "generate"

Phrase: "amyloid-containing fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.97: Proteolytic cleavage of APP was therefore examined in whole activated platelets. 

Phrase: "Proteolytic cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "therefore"

Phrase: "examined in whole activated platelets."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0005821:Platelets [Cell]
   760   C0332128:Examined [Finding]
   760   C0444667:Whole [Quantitative Concept]
   760   C1879547:Activated [Activity]
   760   C1963076:Platelets [Finding]
   726 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.98: Platelets were incubated with different agonists in the presence or absence of calcium, lysed, and APP immunoreactivities were analyzed by Western blotting with an affinity-purified antibody to the cytoplasmic domain of APP (antibody 369A). 

Phrase: "Platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "incubated with different agonists"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243192:agonists [Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1705242:Different [Qualitative Concept]
   770   C2987634:agonists [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of calcium,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "APP immunoreactivities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0597879:immunoreactivity [Molecular Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with an affinity-purified antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to the cytoplasmic domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511625:Cytoplasmic Domain [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(antibody 369A"

Phrase: ")."
Processing 00000000.tx.99: This antibody has been shown to label the 140-150-kDa APP and smaller fragments of APP, and does not detect COOH-terminal truncated soluble APP (Buxbaum et al., 1990; Li et al., 1994; Nordstedt et al., 1991). 

Phrase: "This antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown to label"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0181496:Label [Manufactured Object]
   790   C2827499:Label [Governmental or Regulatory Activity]
   756   C1547282:Show [Intellectual Product]

Phrase: "the 140-150-kDa APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "smaller fragments of APP,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "COOH-terminal truncated soluble APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   845   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   845   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   829   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0011560:Amyloid [Pathologic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1709634:Precursor [Idea or Concept]
   795   C1749467:soluble [Cell Component]
   795   C1948047:Soluble [Qualitative Concept]

Phrase: "(Buxbaum et al.,"

Phrase: "1990"

Phrase: "; Li et al.,"

Phrase: "1994"

Phrase: "; Nordstedt et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.100: The present study showed that resting platelets (PGE-treated) contained APP (Fig. 1A, lanes 1 and 5), in agreement with our previous report (Li et al., 1994). 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that resting platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "(PGE-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033559:PGE [Biologically Active Substance,Eicosanoid]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: ")"

Phrase: "contained APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with our previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(Li et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.101: The APP was also detected by mAb 6E10 which recognizes an epitope of A4 (data not shown). 

Phrase: "The APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "detected by mAb 6E10"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0442726:Detected [Finding]
   760   C0746619:monoclonal [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "recognizes"

Phrase: "an epitope of A4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003316:Epitope [Immunologic Factor]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.102: Activation of platelets by physiological stimulants (a combination of thrombin and collagen) or by nonphysiological agonists (PMA or calcium ionophore A23187) in either calcium-free (EHS buffer containing 1 mM EDTA) or calcium-containing medium (Tyrode buffer containing 2 mM CaCl, 1 mM MgCl) resulted in decreased immunostaining of a APP band (Fig. 1A, lanes 2-4 and 6-8). 

Phrase: "Activation of platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0032173:Platelet Activation [Organ or Tissue Function]
   790   C1879547:Activation [Activity]

Phrase: "by physiological stimulants"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0304402:STIMULANTS [Pharmacologic Substance]
   827 E C0002763:stimulant [Pharmacologic Substance]
   827 E C3536952:Stimulant [Pharmacologic Substance]

Phrase: "("

Phrase: "a combination of thrombin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: ")"

Phrase: "or by nonphysiological agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243192:agonists [Pharmacologic Substance]
   770   C2987634:agonists [Pharmacologic Substance]

Phrase: "(PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: "or"

Phrase: "calcium ionophore A23187"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0878412:A23187 [Antibiotic,Organic Chemical]
   734   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "in either calcium-free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]

Phrase: "(EHS buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mM EDTA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "calcium-containing medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "(Tyrode buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2 mM CaCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1426700:CACL [Gene or Genome]

Phrase: "1 mM MgCl"

Phrase: ")"

Phrase: "resulted in decreased immunostaining of a APP band"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   775   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Amyloid A
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0175723:Band [Medical Device]
   739   C0205216:Decreased [Quantitative Concept]
   739   C0392756:Decreased [Qualitative Concept]
   739   C0439645:Band [Spatial Concept]
   739   C0442797:decreased [Qualitative Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1521913:band [Cell Component]
   739   C1709634:Precursor [Idea or Concept]
   706 E C0547047:Decrease [Quantitative Concept]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lanes 2-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "6-8"

Phrase: ")."
Processing 00000000.tx.103: A23187 together with calcium was the most potent treatment as it induced complete cleavage of APP (Fig. 1A, lane 8, and Fig. 2A, lane 4). 

Phrase: "A23187 together with calcium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "was"

Phrase: "the most potent treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "as"

Phrase: "it"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "complete cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lane 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "Fig. 2A,"

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.104: Platelet activation and degranulation progressed under these conditions with or without calcium, as indicated by release of APP into the medium (Fig. 1B). 

Phrase: "Platelet activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032173:Platelet Activation [Organ or Tissue Function]
   861   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "degranulation"

Phrase: "progressed under these conditions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C1272688:progressed [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737 E C1280477:Progress [Functional Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "with"

Phrase: "or without calcium,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   790   C0006726:Calcium [Inorganic Chemical]
   790   C2936886:Calcium [Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated by release of APP"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030685:Release [Health Care Activity]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1444656:Indicated [Finding]
   748   C1709634:Precursor [Idea or Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "into the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: Figure 1: Western blotting analysis of cleavage of APP in intact platelets and appearance of APP and GPIb in the medium, indicating that the presence of A23187 plus calcium induces maximum APP degradation and GPIb release. 

Phrase: "Figure 1"

Phrase: ":"

Phrase: "Western blotting analysis of cleavage of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0949466:Western blot analysis [Laboratory Procedure]
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "in intact platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "appearance of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233426:Appearance [Organism Attribute]
   760   C0700364:Appearance [Qualitative Concept]

Phrase: "and"

Phrase: "GPIb in the medium,"

Phrase: "indicating"

Phrase: "that"

Phrase: "the presence of A23187 plus calcium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "maximum APP degradation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C1327161:amyloid precursor protein degradation [Molecular Function]
   840   C0597297:Protein Degradation [Molecular Function]
   840   C0597304:Protein Degradation [Molecular Function]
   840   C1623036:Protein Degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "and"

Phrase: "GPIb release."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.106: Washed platelets were activated with the agonists indicated in the presence of 2 mM CaCl (+Ca) or 1 mM EDTA (-Ca) and platelet lysates and medium were prepared. 

Phrase: "Washed platelets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005821:Platelets [Cell]
   861   C1548982:Washed [Idea or Concept]
   861   C1963076:Platelets [Finding]
   827 E C0441648:Wash [Activity]

Phrase: "were"

Phrase: "activated with the agonists"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0243192:agonists [Pharmacologic Substance]
   770   C1879547:Activated [Activity]
   770   C2987634:agonists [Pharmacologic Substance]
   737 E C1515877:Activate [Functional Concept]

Phrase: "indicated in the presence of 2 mM CaCl (+Ca)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1426700:CACL [Gene or Genome]
   744   C1444656:Indicated [Finding]

Phrase: "or"

Phrase: "1 mM EDTA (-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "Ca)"

Phrase: "and"

Phrase: "platelet lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "and"

Phrase: "medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "prepared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.107: Samples were separated by a 8.5% SDS-PAGE gel, transferred to PVDF membranes, and then probed with indicated antibodies. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "separated by a 8.5% SDS-PAGE gel,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   782   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   760   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   760   C0596607:Gel Electrophoresis [Laboratory Procedure]
   757 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   739   C0013855:Electrophoresis [Laboratory Procedure]
   739   C0017243:Gel [Biomedical or Dental Material]
   739   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   739   C0086972:Separated [Finding]
   739   C0443299:separated [Spatial Concept]
   739   C0687118:Separated [Functional Concept]
   739   C1382104:Gel [Substance]

Phrase: "transferred to PVDF membranes,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0025255:Membranes [Tissue]
   770   C0071710:PVDF [Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C0596901:Membrane [Cell Component]
   737 E C1705822:Transfer [Activity]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "probed with indicated antibodies."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C1444656:Indicated [Finding]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.108: The primary antibody was detected with alkaline phosphatase-conjugated secondary antibody by chromogenic reaction. 

Phrase: "The primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "detected with alkaline phosphatase-conjugated secondary antibody"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027627:secondary [Neoplastic Process]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0442726:Detected [Finding]
   748   C0522529:Conjugated [Spatial Concept]
   748   C1149880:phosphatase [Molecular Function]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1979842:Alkaline [Qualitative Concept]

Phrase: "by chromogenic reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.109: Panel A, lysates derived from 2 10 platelets and analyzed with an antibody to the COOH terminus of APP (369A). 

Phrase: "Panel A,"

Phrase: "lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "derived from 2 10 platelets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005821:Platelets [Cell]
   760   C1441547:Derived [Qualitative Concept]
   760   C1963076:Platelets [Finding]
   760   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "analyzed with an antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0936012:Analyzed [Research Activity]

Phrase: "to the COOH terminus"

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(369A"

Phrase: ")."
Processing 00000000.tx.110: Panel B, platelet incubation medium derived from 2 10 platelets were analyzed with an antibody to the N terminus of APP (mAb 22C11). 

Phrase: "Panel B,"

Phrase: "platelet incubation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "derived from 2 10 platelets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005821:Platelets [Cell]
   760   C1441547:Derived [Qualitative Concept]
   760   C1963076:Platelets [Finding]
   760   C3245521:derived [Idea or Concept]

Phrase: "were"

Phrase: "analyzed with an antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0936012:Analyzed [Research Activity]

Phrase: "to the N terminus"

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(mAb 22C11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.111: Panel C, platelet incubation medium derived from 1 10 platelets were analyzed with an antibody to GPIb (WM23). 

Phrase: "Panel C,"

Phrase: "platelet incubation medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "derived from 1 10 platelets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005821:Platelets [Cell]
   760   C1441547:Derived [Qualitative Concept]
   760   C1963076:Platelets [Finding]
   760   C3245521:derived [Idea or Concept]

Phrase: "were"

Phrase: "analyzed with an antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0936012:Analyzed [Research Activity]

Phrase: "to GPIb"

Phrase: "(WM23"

Phrase: ")."
Processing 00000000.tx.112: The relative mass of standard protein markers is shown on the left. 

Phrase: "The relative mass of standard protein markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C3152252:Mass [Quantitative Concept]

Phrase: "is"

Phrase: "shown on the left."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1552822:left [Functional Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.113: The localization of APP and GC immunoreactivities are indicated on the right. 

Phrase: "The localization of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597704:protein localisation [Cell Function]
   783   C1159772:Protein Localization [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "GC immunoreactivities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "are"

Phrase: "indicated on the right."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.114: T/C, thrombin plus collagen; 

Phrase: "T/C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "thrombin plus collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C1167364:collagen [Cell Component]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.115: A, calcium ionophore A23187. 

Phrase: "A,"

Phrase: "calcium ionophore A23187."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0878412:A23187 [Antibiotic,Organic Chemical]
   734   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.116: Figure 2: Western blot analysis of APP degradation within platelets and GPIb appearance in the medium in the presence of protease inhibitors and metal ions, showing that APP degradation and GPIb release are partially inhibited by calpeptin and EGTA. 

Phrase: "Figure 2"

Phrase: ":"

Phrase: "Western blot analysis of APP degradation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   767   C1514534:Protein Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: "within platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "GPIb appearance in the medium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233426:Appearance [Organism Attribute]
   760   C0700364:Appearance [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "metal ions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that APP degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "GPIb release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "partially"

Phrase: "inhibited by calpeptin"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "and"

Phrase: "EGTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.117: A, fluorogram to show the inhibition of APP degradation. 

Phrase: "A,"

Phrase: "fluorogram to"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the inhibition of APP degradation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1514541:Protein Degradation Inhibition [Physiologic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]
Processing 00000000.tx.118: Washed platelets were treated with the agonists in the presence of the indicated agents. 

Phrase: "Washed platelets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005821:Platelets [Cell]
   861   C1548982:Washed [Idea or Concept]
   861   C1963076:Platelets [Finding]
   827 E C0441648:Wash [Activity]

Phrase: "were"

Phrase: "treated with the agonists"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0243192:agonists [Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   770   C2987634:agonists [Pharmacologic Substance]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the indicated agents."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.119: Platelet lysates were prepared and analyzed by Western blotting as described in the legend to Fig. 

Phrase: "Platelet lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "to Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 1 except that the primary antibody 369A was detected by chemiluminescence. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that"

Phrase: "the primary antibody 369A"

Phrase: "was"

Phrase: "detected by chemiluminescence."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   790   C0442726:Detected [Finding]
   790   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.121: B, inhibition profile of GPIb release. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "inhibition profile of GPIb release."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1979963:Profile [Laboratory Procedure]
   760   C2003903:Profile [Functional Concept]
Processing 00000000.tx.122: Platelet incubation media were analyzed with an antibody to GPIb (WM23). 

Phrase: "Platelet incubation media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "analyzed with an antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0936012:Analyzed [Research Activity]

Phrase: "to GPIb"

Phrase: "(WM23"

Phrase: ")."
Processing 00000000.tx.123: T/C, thrombin plus collagen; 

Phrase: "T/C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "thrombin plus collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C1167364:collagen [Cell Component]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.124: A, A23187; 

Phrase: "A,"

Phrase: "A23187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.125: Cal, calpeptin. 

Phrase: "Cal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556156:[Cal] [Quantitative Concept]

Phrase: "calpeptin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.126: Platelet APP could also be detected by Western blotting using the chemiluminescence visualization technique, which is more sensitive than chromogenic visualization (Fig. 2A). 

Phrase: "Platelet APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C0582509:platelet precursor [Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the chemiluminescence visualization technique,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0454044:Visualisation technique [Therapeutic or Preventive Procedure]
   827   C0449851:Technique [Functional Concept]
   743 E C0025664:techniques [Intellectual Product]

Phrase: "which"

Phrase: "is"

Phrase: "more sensitive than chromogenic visualization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332324:Sensitive [Functional Concept]
   760   C1550474:sensitive [Idea or Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.127: Following activation, APP disappeared and two faint bands of 90-95 kDa labeled by 369A appeared, these bands were not present in the PGE-treated platelets (Fig. 2A, lanes 1 and 4). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "disappeared"

Phrase: "and"

Phrase: "two faint bands of 90-95 kDa"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0175723:Bands [Medical Device]
   714 E C0439645:Band [Spatial Concept]
   714 E C1521913:band [Cell Component]

Phrase: "labeled by 369A"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: ","

Phrase: "these bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in the PGE-treated platelets"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0005821:Platelets [Cell]
   753   C0033559:PGE [Biologically Active Substance,Eicosanoid]
   753   C0150312:Present [Quantitative Concept]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C0449450:Present [Idea or Concept]
   753   C1522326:Treated [Functional Concept]
   753   C1963076:Platelets [Finding]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(Fig. 2A,"

Phrase: "lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.128: By semi-quantitation using densitometric analysis, only about 60-70% of APP was cleaved when platelets were stimulated by thrombin plus collagen or by PMA, in contrast to nearly 100% of APP being degraded in A23187-treated platelets. 

Phrase: "By semi-quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "densitometric analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "only about 60-70% of APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205171:Only [Quantitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C1720467:Only [Intellectual Product]

Phrase: "was"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "when"

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "stimulated by thrombin plus collagen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0332287:Plus [Qualitative Concept]
   760   C1167364:collagen [Cell Component]
   760   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or by PMA,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]
   800   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   748   C0031588:phorbol [Organic Chemical]
   748   C0070750:Phorbol [Organic Chemical]
   748   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "in contrast to nearly 100%"

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "being"

Phrase: "degraded in A23187-treated platelets."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0005821:Platelets [Cell]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C0878412:A23187 [Antibiotic,Organic Chemical]
   760   C1522326:Treated [Functional Concept]
   760   C1881707:DEGRADED [Phenomenon or Process]
   760   C1963076:Platelets [Finding]
   726 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.129: In order to determine whether the disappearance of the APP was due to a proteolytic process, washed platelets were preincubated with various protease inhibitors for 15 min before addition of A23187. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the disappearance of the APP"

Phrase: "was due to a proteolytic process,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0678226:Due to [Functional Concept]
           due
   783   C0013277:Due Process [Regulation or Law]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0597304:Proteolytic [Molecular Function]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1421478:WAS [Gene or Genome]
   753   C1522240:Process [Phenomenon or Process]
   753   C1947941:proteolytic [Enzyme]
   753   C3146286:Due [Idea or Concept]

Phrase: "washed platelets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005821:Platelets [Cell]
   861   C1548982:Washed [Idea or Concept]
   861   C1963076:Platelets [Finding]
   827 E C0441648:Wash [Activity]

Phrase: "were"

Phrase: "preincubated with various protease inhibitors"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   773 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   760   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1947941:Protease [Enzyme]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "before addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of A23187."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]
Processing 00000000.tx.130: Cleavage of APP in A23187-treated platelets was inhibited by calpeptin, TLCK, E64d, and EGTA as well as metal ions, Zn, Cu, and Co (Fig. 2A and ). 

Phrase: "Cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597304:Protein Cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "in A23187-treated platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005821:Platelets [Cell]
   827   C1963076:Platelets [Finding]

Phrase: "was"

Phrase: "inhibited by calpeptin,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "E64d,"

Phrase: "and"

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "as well as"

Phrase: "metal ions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "Zn,"

Phrase: "Cu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1177210:Cu++ [Inorganic Chemical,Pharmacologic Substance]
  1000   C2347872:Cu+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Co (Fig. 2A"

Phrase: "and"

Phrase: ")."
Processing 00000000.tx.131: Pretreatment of platelets with calpeptin, EGTA, or Zn protected 40-60% of APP from degradation. 

Phrase: "Pretreatment of platelets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "with calpeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "or"

Phrase: "Zn"

Phrase: "protected"

Phrase: "40-60% of APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439509:/40 [Temporal Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "from degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.132: Cu and Co blocked almost all of the APP degradation (90%). 

Phrase: "Cu"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1177210:Cu++ [Inorganic Chemical,Pharmacologic Substance]
  1000   C2347872:Cu+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Co"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "almost"

Phrase: "all of the APP degradation"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   853   C1327161:amyloid precursor protein degradation [Molecular Function]
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0597297:Protein Degradation [Molecular Function]
   778   C0597304:Protein Degradation [Molecular Function]
   778   C1623036:Protein Degradation [Molecular Function]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243125:degradation [Functional Concept]
   748   C0444868:All [Quantitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0699900:Degradation [Organism Function]
   748   C1709634:Precursor [Idea or Concept]
   748   C3539085:All [Idea or Concept]

Phrase: "(90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.133: A lower concentration of calpeptin (2 g/ml) also partially inhibited APP degradation (data not shown). 

Phrase: "A lower concentration of calpeptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "(2 g/ml) also partially"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1300565:g/mL [Quantitative Concept]
   804   C0439267:g% [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]
   804   C0740116:+2 [Quantitative Concept]
   804   C2827735:2+ [Quantitative Concept]
   804   C2981700:2+ [Classification]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "APP degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.134: APP degradation induced by thrombin or PMA was also inhibited by calpeptin and EGTA, similar to that found by A23187 induction (data not shown). 

Phrase: "APP degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "induced by thrombin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "or"

Phrase: "PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: "was"

Phrase: "also"

Phrase: "inhibited by calpeptin"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "and"

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "found by A23187 induction"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0150312:Found [Quantitative Concept]
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
   770   C0878412:A23187 [Antibiotic,Organic Chemical]
   737 E C0243095:Find [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.135: Cleavage of APPIs Not Inhibited by Agents That Affect the Acidic Compartments There is considerable evidence suggesting a role for lysosomal and acidic compartments in the processing of APP (Busciglio et al., 1993; Caporaso et al., 1992; Haass et al., 1992; Knops et al., 1992). 

Phrase: "Cleavage of APPIs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Inhibited by Agents"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0311403:Inhibited [Qualitative Concept]
   756   C0450442:Agent [Chemical Viewed Functionally]
   756   C1254351:Agent [Pharmacologic Substance]
   756   C1521826:Agent [Intellectual Product]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "That"

Phrase: "Affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the Acidic Compartments There"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1185625:Compartments [Body Space or Junction]
   827   C1382196:Compartments [Natural Phenomenon or Process]
   793 E C2986730:Compartment [Spatial Concept]

Phrase: "is"

Phrase: "considerable evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role for lysosomal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "acidic compartments in the processing of APP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C1185625:Compartments [Body Space or Junction]
   742   C1382196:Compartments [Natural Phenomenon or Process]
   708 E C2986730:Compartment [Spatial Concept]

Phrase: "(Busciglio et al.,"

Phrase: "1993"

Phrase: "; Caporaso et al.,"

Phrase: "1992"

Phrase: "; Haass et al.,"

Phrase: "1992"

Phrase: "; Knops et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.136: Involvement of a lysosomal or acidic compartment in the degradation of APP was examined by preincubating whole platelets with NHCl, chloroquine, or monensin before addition of A23187. 

Phrase: "Involvement of a lysosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "or"

Phrase: "acidic compartment in the degradation of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1185625:Compartment [Body Space or Junction]
   742   C2986730:Compartment [Spatial Concept]

Phrase: "was"

Phrase: "examined by preincubating whole platelets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005821:Platelets [Cell]
   760   C0332128:Examined [Finding]
   760   C0444667:Whole [Quantitative Concept]
   760   C1963076:Platelets [Finding]

Phrase: "with NHCl,"

Phrase: "chloroquine,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   944 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "monensin before addition of A23187."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026408:Monensin [Antibiotic,Organic Chemical]
Processing 00000000.tx.137: The APP immunoreactivity in the platelet lysate was analyzed by Western blotting. 

Phrase: "The APP immunoreactivity in the platelet lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "analyzed by Western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.138: None of these agents inhibited the cleavage of APP (), suggesting that the enzymes of lysosomal or acidic compartments were not involved in the degradation of APP of platelets. 

Phrase: "None of these agents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737   C1521826:Agent [Intellectual Product]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the enzymes of lysosomal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0391845:Lysosomal enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0014442:Enzymes [Enzyme,Organic Chemical]
   770   C0014445:enzymes [Functional Concept]

Phrase: "or"

Phrase: "acidic compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in the degradation of APP of platelets."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   799   C1327161:amyloid precursor protein degradation [Molecular Function]
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0597297:Protein Degradation [Molecular Function]
   757   C0597304:Protein Degradation [Molecular Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1623036:Protein Degradation [Molecular Function]
   741   C0582509:platelet precursor [Biologically Active Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0005821:Platelets [Cell]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0243125:degradation [Functional Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0699900:Degradation [Organism Function]
   739   C1314939:Involved [Functional Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C1963076:Platelets [Finding]
Processing 00000000.tx.139: Proteolysis and release of platelet membrane glycoproteins GPIb to the medium as a result of A23187 plus calcium treatment have been reported (McGowan et al., 1983). 

Phrase: "Proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "and"

Phrase: "release of platelet membrane glycoproteins GPIb"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "to the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of A23187 plus calcium treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(McGowan et al.,"

Phrase: "1983"

Phrase: ")."
Processing 00000000.tx.140: To confirm this result, we separated the platelets from the incubation medium and analyzed the appearance of glycocalicin (GC, an extracellular region of GPIb) in the medium by Western blotting. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "we"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "the platelets from the incubation medium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005821:Platelets [Cell]
   753   C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the appearance of glycocalicin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233426:Appearance [Organism Attribute]
   770   C0700364:Appearance [Qualitative Concept]

Phrase: "(GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3537453:GC [Gene or Genome]

Phrase: "an extracellular region of GPIb"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0521119:extracellular region [Cell Component]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: ")"

Phrase: "in the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "by Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.141: Increased amounts of GC were detected when platelets were treated with thrombin plus collagen, PMA, or A23187, and maximum release of GC was found with A23187 plus calcium treatment (Fig. 1C). 

Phrase: "Increased amounts of GC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "treated with thrombin plus collagen,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0332287:Plus [Qualitative Concept]
   760   C1167364:collagen [Cell Component]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: "or"

Phrase: "A23187,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "maximum release of GC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "found with A23187 plus calcium treatment"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0150312:Found [Quantitative Concept]
   753   C0332287:Plus [Qualitative Concept]
   753   C0878412:A23187 [Antibiotic,Organic Chemical]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C2936886:Calcium [Pharmacologic Substance]
   753   C3538994:TREATMENT [Research Activity]
   719 E C0243095:Find [Finding]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.142: The release of GC to the medium was partially inhibited by pretreatment of platelets with calpeptin, TLCK, E64d, and EGTA, but not by other protease inhibitors including PMSF, DFP, pepstatin (Fig. 2B). 

Phrase: "The release of GC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "to the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "partially"

Phrase: "inhibited by pretreatment of platelets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0005821:Platelets [Cell]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1550147:Pretreatment [Substance]
   760   C1963076:Platelets [Finding]
   760   C2709094:pre treatment [Temporal Concept]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]

Phrase: "with calpeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "E64d,"

Phrase: "and"

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "but"

Phrase: "not by other protease inhibitors"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   773 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   760   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C1518422:Not [Functional Concept]
   760   C1947941:Protease [Enzyme]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "DFP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022181:Diisopropyl fluorophosphate [Hazardous or Poisonous Substance,Organophosphorus Compound,Pharmacologic Substance]
   861   C0060567:fluorophosphate [Inorganic Chemical]

Phrase: "pepstatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.143: Identification of APP CTF Containing A4 Initially, we examined the A4-containing CTF of APP by Western blotting of total platelet lysates. 

Phrase: "Identification of APP CTF Containing A4 Initially,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0020792:Identification [Mental Process]
   738   C0205396:Identification [Qualitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the A4-containing CTF of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "of total platelet lysates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]
Processing 00000000.tx.144: A lysate from PGE-treated platelets was found to contain a 22-kDa COOH-terminal fragment of APP which was recognized by antibody 369A (Fig. 3A, lane 1). 

Phrase: "A lysate from PGE-treated platelets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a 22-kDa COOH-terminal fragment of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "recognized by antibody 369A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 3A,"

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.145: Two different approaches then confirmed that this 22-kDa band was a CTF of APP. 

Phrase: "Two different approaches then"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449445:Approaches [Spatial Concept]
   812   C1292724:Approaches [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "this 22-kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "a CTF of APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.146: First, when the antibody was preincubated with the peptide homologue used to raise antibody 369A, the staining was abolished (Fig. 3B). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "when"

Phrase: "the antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "preincubated with the peptide homologue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C1334043:Homologue [Gene or Genome]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "raise"

Phrase: "antibody 369A,"

Phrase: "the staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "abolished"

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.147: Second, other antibodies including the polyclonal Ab 730 (anti-A4) (Fig. 3A, lane 2), anti-CT (raised to 704-730 of APP) (Fig. 3A, lane 3), 92/9 (anti-APP) (Fig. 3A, lane 4), and mAb 6E10 (anti-A4) (Fig. 4A) recognized this 22-kDa fragment. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "other antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the polyclonal Ab 730"

Phrase: "(anti-A4"

Phrase: ")"

Phrase: "(Fig. 3A,"

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-CT ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "raised to 704-730 of APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0442818:Raised [Quantitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "(Fig. 3A,"

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "92/9"

Phrase: "(anti-APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(Fig. 3A,"

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mAb 6E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(anti-A4"

Phrase: ")"

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "recognized"

Phrase: "this 22-kDa fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.148: Since the epitope for 6E10 is within the sequence 1-17 of A4 (Kim et al., 1990), this result indicated that the 22-kDa fragment also contains most of the A4 sequence, in addition to the COOH-terminal sequence of APP. 

Phrase: "Since"

Phrase: "the epitope for 6E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003316:Epitope [Immunologic Factor]

Phrase: "is within the sequence 1-17 of A4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "(Kim et al.,"

Phrase: "1990"

Phrase: ")"

Phrase: ","

Phrase: "this result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the 22-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "also"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "most of the A4 sequence,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205393:Most [Quantitative Concept]
   760   C1519249:Sequence [Functional Concept]

Phrase: "in addition to the COOH-terminal sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "of APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.149: The 22-kDa fragment was reproducibly detected in platelets from several normal subjects. 

Phrase: "The 22-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "reproducibly"

Phrase: "detected in platelets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0005821:Platelets [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C1963076:Platelets [Finding]

Phrase: "from several normal subjects."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0205307:Normal [Qualitative Concept]
   827   C0439166:% normal [Quantitative Concept]
   827   C2347086:% Normal [Quantitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]
Processing 00000000.tx.150: The 369A antibody also recognized other CTFs with molecular mass of 15, 16, and 18 kDa (Fig. 3). 

Phrase: "The 369A antibody also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognized"

Phrase: "other CTFs with molecular mass of 15,"

Phrase: "16,"

Phrase: "and"

Phrase: "18 kDa (Fig. 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.151: Since these bands were present in both lysates from PGE- and A23187-treated platelets in similar amounts and therefore were unrelated to the activation process, they were not examined further. 

Phrase: "Since"

Phrase: "these bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "present in both lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "from PGE-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033559:PGE [Biologically Active Substance,Eicosanoid]

Phrase: "and"

Phrase: "A23187-treated platelets in similar amounts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005821:Platelets [Cell]
   753   C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "therefore"

Phrase: "were"

Phrase: "unrelated to the activation process,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445356:Unrelated [Finding]
   760   C1704623:Unrelated [Qualitative Concept]

Phrase: "they"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "further."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]
Processing 00000000.tx.152: Figure 3: Characterization of a 22-kDa A4 containing fragment in lysates of PGE-treated platelets by Western blot. 

Phrase: "Figure 3"

Phrase: ":"

Phrase: "Characterization of a 22-kDa A4 containing fragment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "in lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "of PGE-treated platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005821:Platelets [Cell]
   827   C1963076:Platelets [Finding]

Phrase: "by Western blot."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.153: Platelets isolated in the presence of PGE were lysed and lyastes derived from 2 10 platelets were loaded onto a 15% SDS-PAGE gel and analyzed as described in the legend to Fig. 

Phrase: "Platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "isolated in the presence of PGE"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0033559:PGE [Biologically Active Substance,Eicosanoid]
   753   C0205409:Isolated [Functional Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "lyastes"

Phrase: "derived from 2 10 platelets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005821:Platelets [Cell]
   760   C1441547:Derived [Qualitative Concept]
   760   C1963076:Platelets [Finding]
   760   C3245521:derived [Idea or Concept]

Phrase: "were"

Phrase: "loaded onto a 15% SDS-PAGE gel"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   818   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   790   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   764   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   764   C0596607:Gel Electrophoresis [Laboratory Procedure]
   762 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   742   C0013855:Electrophoresis [Laboratory Procedure]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   742   C1382104:Gel [Substance]
   742   C1708715:Loaded [Activity]
   708 E C1550025:Load [Idea or Concept]
   708 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "to Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.154: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.155: A, APP CTFs were analyzed with different antibodies. 

Phrase: "A,"

Phrase: "APP CTFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed with different antibodies."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0936012:Analyzed [Research Activity]
   770   C1705242:Different [Qualitative Concept]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.156: Lane 1, antibody to the COOH terminus of APP (369A); 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "antibody to the COOH terminus of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   784   C1445860:Antibody to protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Protein antibody
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(369A"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.157: lane 2, antibody to the 1-40 sequence of A4 (730); 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "antibody to the 1-40 sequence of A4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(730"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.158: lane 3, antibody to the 704-730 sequence of APP (anti-CT); 

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "antibody to the 704-730 sequence of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C1445860:Antibody to protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Protein antibody
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.159: and lane 4, antibody to purified human brain APP (92/9). 

Phrase: "and"

Phrase: "lane 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "antibody to purified human brain APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1445860:Antibody to protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Protein antibody
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(92/9"

Phrase: ")."
Processing 00000000.tx.160: B, the immunoreactivity to the 22-kDa band was abolished in the presence of the peptide used to raise the 369A antibody (lane 1). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the immunoreactivity to the 22-kDa band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "abolished in the presence of the peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "raise"

Phrase: "the 369A antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.161: The relative mass of standard protein markers is shown on the left. 

Phrase: "The relative mass of standard protein markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C3152252:Mass [Quantitative Concept]

Phrase: "is"

Phrase: "shown on the left."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1552822:left [Functional Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.162: The localization of APP COOH-terminal immunoreactivities are indicated on the right. 

Phrase: "The localization of APP COOH-terminal immunoreactivities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0597704:protein localisation [Cell Function]
   762   C1159772:Protein Localization [Cell Function]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]

Phrase: "are"

Phrase: "indicated on the right."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.163: Only the 22-kDa band was recognized by all four antibodies. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the 22-kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "recognized by all four antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205450:Four [Quantitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.164: Figure 4: Western blot showing that cleavage of 22-CTF of APP in activated platelets required external calcium. 

Phrase: "Figure 4"

Phrase: ":"

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that cleavage of 22-CTF of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0597304:Protein Cleavage [Molecular Function]
   738   C0010813:cleavage [Cell Function]
   738   C0596311:Cleavage [Phenomenon or Process]
   738   C1330957:cleavage [Cell Function]

Phrase: "in activated platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "external calcium."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.165: Washed platelets were stimulated with the indicated agonists in the presence of 2 mM CaCl (+Ca) or 1 mM EDTA (-Ca) and analyzed as described in the legend to Fig. 

Phrase: "Washed platelets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005821:Platelets [Cell]
   861   C1548982:Washed [Idea or Concept]
   861   C1963076:Platelets [Finding]
   827 E C0441648:Wash [Activity]

Phrase: "were"

Phrase: "stimulated with the indicated agonists"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0243192:agonists [Pharmacologic Substance]
   760   C1444656:Indicated [Finding]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   760   C2987634:agonists [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 2 mM CaCl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1426700:CACL [Gene or Genome]

Phrase: "(+Ca"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426700:CACL [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "1 mM EDTA (-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "Ca)"

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "to Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.166: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.167: Panel A, platelet lysates were analyzed with antibody 369A or 6E10; 

Phrase: "Panel A,"

Phrase: "platelet lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed with antibody 369A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0936012:Analyzed [Research Activity]

Phrase: "or"

Phrase: "6E10"

Phrase: ";"
Processing 00000000.tx.168: panel B, platelet lysates were analyzed with anti-talin. 

Phrase: "panel B,"

Phrase: "platelet lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed with anti-talin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0936012:Analyzed [Research Activity]
   770   C1420760:TALIN [Gene or Genome]
Processing 00000000.tx.169: ``*'' indicates the new 17-kDa fragment generated upon platelet activation. 

Phrase: "``"

Phrase: "*''"

Phrase: "indicates"

Phrase: "the new 17-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "generated upon platelet activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0032173:Platelet Activation [Organ or Tissue Function]
   770   C0005821:Platelet [Cell]
   770   C1879547:Activation [Activity]
   770   C3146294:Generated [Activity]
Processing 00000000.tx.170: T/C, thrombin plus collagen; 

Phrase: "T/C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "thrombin plus collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C1167364:collagen [Cell Component]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.171: A, A23187. 

Phrase: "A,"

Phrase: "A23187."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]
Processing 00000000.tx.172: Cleavage of the 22-kDa CTF of APP in Whole Platelets is a Calcium-dependent Process We next examined the degradation of the APP 22-CTF associated with platelet activation. 

Phrase: "Cleavage of the 22-kDa CTF of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C0597304:Protein Cleavage [Molecular Function]
   736   C0010813:cleavage [Cell Function]
   736   C0596311:Cleavage [Phenomenon or Process]
   736   C1330957:cleavage [Cell Function]

Phrase: "in Whole Platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "is"

Phrase: "a Calcium-dependent Process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the degradation of the APP 22-CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   792   C1327161:amyloid precursor protein degradation [Molecular Function]
   754   C0597297:Protein Degradation [Molecular Function]
   754   C0597304:Protein Degradation [Molecular Function]
   754   C1623036:Protein Degradation [Molecular Function]
   738   C0243125:degradation [Functional Concept]
   738   C0699900:Degradation [Organism Function]

Phrase: "associated with platelet activation."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0032173:Platelet Activation [Organ or Tissue Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C1441093:Platelet associated [Immunologic Factor]
   770   C0005821:Platelet [Cell]
   770   C1879547:Activation [Activity]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.173: Platelets incubated with various agonists were lysed and the APP immunoreactive polypeptides in the lysate were analyzed by Western blotting using antibody 369A. 

Phrase: "Platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "incubated with various agonists"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243192:agonists [Pharmacologic Substance]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C2987634:agonists [Pharmacologic Substance]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "the APP immunoreactive polypeptides in the lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody 369A."
Processing 00000000.tx.174: When platelets were incubated with the calcium ionophore A23187 (1 M) in a calcium-containing medium, the 22-kDa band (Fig. 4A) disappeared and a 17-CTF was observed (Fig. 4A, lane 8, +Ca). 

Phrase: "When"

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "incubated with the calcium ionophore A23187"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0521966:Calcium ionophore A23187 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0444420:Calcium ionophore [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0022022:Ionophore [Pharmacologic Substance]
   753   C0878412:A23187 [Antibiotic,Organic Chemical]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1517596:ionophore [Molecular Function]
   753   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M) in a calcium-containing medium,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0009458:Medium [Intellectual Product]
   753   C0332256:Containing [Functional Concept]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439536:Medium [Quantitative Concept]
   753   C0441923:M+ [Intellectual Product]
   753   C1705217:Medium [Substance]
   753   C2700400:Containing [Activity]
   753   C2936886:Calcium [Pharmacologic Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "the 22-kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "disappeared"

Phrase: "and"

Phrase: "a 17-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "lane 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "+Ca"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426700:CACL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.175: The 17-CTF was not present in the PGE-treated platelets (Fig. 4A, lane 5, +Ca), and was not recognized by antibody 6E10 (Fig. 4A, lane 4, +Ca). 

Phrase: "The 17-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in the PGE-treated platelets"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0005821:Platelets [Cell]
   753   C0033559:PGE [Biologically Active Substance,Eicosanoid]
   753   C0150312:Present [Quantitative Concept]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C0449450:Present [Idea or Concept]
   753   C1522326:Treated [Functional Concept]
   753   C1963076:Platelets [Finding]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "lane 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "+Ca"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426700:CACL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recognized by antibody 6E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "lane 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "+Ca"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426700:CACL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.176: This process was dependent on the presence of external calcium, since platelets treated with A23187 in a calcium-free medium did not lead to the degradation of the 22-kDa CTF, nor to the generation of the 17-kDa CTF (Fig. 4A, lanes 4 and 8, -Ca), even though platelets were stirred in both situations to maximize platelet activation. 

Phrase: "This process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "dependent on the presence of external calcium,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "since"

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "treated with A23187"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0878412:A23187 [Antibiotic,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "in a calcium-free medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0009458:Medium [Intellectual Product]
   827   C0332296:free [Functional Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "lead to the degradation of the 22-kDa CTF,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   738   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   738   C0205088:Terminal [Temporal Concept]
   738   C0243125:degradation [Functional Concept]
   738   C0332255:fragment [Functional Concept]
   738   C0699900:Degradation [Organism Function]
   738   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   738   C1522538:Lead [Functional Concept]
   738   C1532717:kDa [Quantitative Concept]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C1708096:Fragment [Qualitative Concept]
   738   C2348269:Lead [Element, Ion, or Isotope]
   738   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "nor to the generation of the 17-kDa CTF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   738   C0028423:NOR [Geographic Area]
   738   C0028609:NOR [Cell Component]
   738   C0079411:Generation [Temporal Concept]
   738   C0205088:Terminal [Temporal Concept]
   738   C0332255:fragment [Functional Concept]
   738   C1513854:NOR [Mammal]
   738   C1532717:kDa [Quantitative Concept]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C1708096:Fragment [Qualitative Concept]
   738   C3146294:Generation [Activity]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "lanes 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "8, -"

Phrase: "Ca), even"

Phrase: "though"

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "stirred in both situations to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1883171:Stir [Activity]

Phrase: "maximize"

Phrase: "platelet activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032173:Platelet Activation [Organ or Tissue Function]
   861   C1879547:Activation [Activity]
Processing 00000000.tx.177: The cleavage of the 22-CTF in whole platelets was also examined after stimulation with other agonists. 

Phrase: "The cleavage of the 22-CTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "in whole platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "was"

Phrase: "also"

Phrase: "examined after stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332128:Examined [Finding]
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with other agonists."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243192:agonists [Pharmacologic Substance]
  1000   C2987634:agonists [Pharmacologic Substance]
Processing 00000000.tx.178: When platelets were treated with thrombin (1 unit/ml, or even 10 units/ml) and collagen (20 g/ml) or PMA (1 M) in the presence or absence of calcium, degradation of the 22-CTF was not observed (Fig. 4A, lanes 2 and 3; 6 and 7, +Ca and -Ca). 

Phrase: "When"

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "treated with thrombin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(1 unit/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2945590:unit/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "even 10 units/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C2945590:unit/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "(20 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M) in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C0441923:M+ [Intellectual Product]

Phrase: "or"

Phrase: "absence of calcium,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "degradation of the 22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "lanes 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "; 6"

Phrase: "and"

Phrase: "7,"

Phrase: "+Ca"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426700:CACL [Gene or Genome]

Phrase: "and -"

Phrase: "Ca)."
Processing 00000000.tx.179: Under these conditions, however, the platelets were activated, as indicated by increased APP secretion following degranulation (Fig. 1B, lanes 2, 3, 6, and 7). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "however,"

Phrase: "the platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: ","

Phrase: "as"

Phrase: "indicated by increased APP secretion"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1159339:Protein Secretion [Cell Function]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1444656:Indicated [Finding]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "degranulation"

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "lanes 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6,"

Phrase: "and"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.180: Effect of Protease Inhibitors and Metal Ions on the Proteolytic Cleavage of the 22-CTF of APP The effect of different protease inhibitors was examined to identify the classes of proteases which may be involved in the cleavage of the A4-containing 22-CTF. 

Phrase: "Effect of Protease Inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "Metal Ions on the Proteolytic Cleavage of the 22-CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   736   C0022023:Ions [Element, Ion, or Isotope]
   734   C1708097:Fragment Ion [Element, Ion, or Isotope]
   703 E C1700702:ION [Functional Concept]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "The effect of different protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the classes of proteases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "involved in the cleavage of the A4-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1314939:Involved [Functional Concept]
   748   C1330957:cleavage [Cell Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "22-CTF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.181: Platelets were preincubated with protease inhibitors or metal ions for 15 min, then the platelets were treated with A23187. 

Phrase: "Platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "preincubated with protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   799 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1947941:Protease [Enzyme]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "metal ions for 15 min,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0022023:Ions [Element, Ion, or Isotope]
   726 E C1700702:ION [Functional Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "treated with A23187."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0878412:A23187 [Antibiotic,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.182: Platelet lysates were prepared and the APP immunoreactivities were observed by Western blotting using antibody 369A. 

Phrase: "Platelet lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "the APP immunoreactivities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0597879:immunoreactivity [Molecular Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "observed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1441672:Observed [Functional Concept]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody 369A."
Processing 00000000.tx.183: When platelets were preincubated with calpeptin, TLCK, E64d, or EGTA, degradation of the 22-CTF in A23187-treated platelets was inhibited (Fig. 5A). 

Phrase: "When"

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "preincubated with calpeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "E64d,"

Phrase: "or"

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "degradation of the 22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "in A23187-treated platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005821:Platelets [Cell]
   827   C1963076:Platelets [Finding]

Phrase: "was"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.184: Inhibition of the 22-CTF cleavage was also detected with lower concentration of calpeptin at 2 g/ml (data not shown). 

Phrase: "Inhibition of the 22-CTF cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "also"

Phrase: "detected with lower concentration of calpeptin at 2 g/ml (data"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   756   C1300565:g/mL [Quantitative Concept]
   754 E C1637390:mL/g [Quantitative Concept]
   738   C0086045:Concentration [Mental Process]
   738   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   738   C0439267:g% [Quantitative Concept]
   738   C0439526:/mL [Quantitative Concept]
   738   C0441994:Lower [Spatial Concept]
   738   C0442726:Detected [Finding]
   738   C1446561:Concentration [Quantitative Concept]
   738   C1511726:Data [Idea or Concept]
   738   C1511790:Detected [Therapeutic or Preventive Procedure]
   738   C1548802:Lower [Body Location or Region]
   738   C2003888:Lower [Activity]
   738   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.185: Cleavage of the 22-kDa CTF was not inhibited by the serine protease inhibitors PMSF or DFP, or the metalloprotease inhibitors 1,10-phenanthroline or phosphoramidon, or the aspartic protease inhibitor pepstatin A (). 

Phrase: "Cleavage of the 22-kDa CTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited by the serine protease inhibitors PMSF"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   800   C0036733:Serine Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   770   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   770   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   770   C0036734:serine protease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C2717971:Serine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   744   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   744   C0311403:Inhibited [Qualitative Concept]
   744   C1947941:Protease [Enzyme]
   737 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   711 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "DFP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022181:Diisopropyl fluorophosphate [Hazardous or Poisonous Substance,Organophosphorus Compound,Pharmacologic Substance]
   861   C0060567:fluorophosphate [Inorganic Chemical]

Phrase: "or"

Phrase: "the metalloprotease inhibitors 1,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C1418385:METALLOPROTEASE 1 [Gene or Genome]
   884   C1152589:metalloprotease inhibitor [Molecular Function]
   884   C1418824:INHIBITOR 1 [Gene or Genome]
   827   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "10-phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "or"

Phrase: "phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "the aspartic protease inhibitor pepstatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A ("

Phrase: ")."
Processing 00000000.tx.186: Cleavage of the 22-CTF still occurred in the presence of the cysteine protease inhibitors iodoacetamide, or the chymotrypsin-like serine protease inhibitor TPCK, but the intensity of the 17-kDa band was diminished compared to the A23187-treated platelets (). 

Phrase: "Cleavage of the 22-CTF still"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "occurred in the presence of the cysteine protease inhibitors iodoacetamide,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   782   C0010658:Cysteine Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   760   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   760   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0243077:inhibitors [Chemical Viewed Functionally]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1709305:Occurred [Activity]
   739   C1947941:Protease [Enzyme]
   726 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   706 E C1999216:Inhibitor [Qualitative Concept]
   706 E C2745955:OCCUR [Temporal Concept]

Phrase: "or"

Phrase: "the chymotrypsin-like serine protease inhibitor TPCK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0022634:Ketone [Organic Chemical]

Phrase: "but"

Phrase: "the intensity of the 17-kDa band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "compared to the A23187-treated platelets"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0005821:Platelets [Cell]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C0878412:A23187 [Antibiotic,Organic Chemical]
   753   C1522326:Treated [Functional Concept]
   753   C1707455:Compared [Activity]
   753   C1963076:Platelets [Finding]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.187: Preincubation of platelets with Zn, Cu, or Co inhibited the cleavage of 22-CTF, while Fe did not have any inhibitory effect (). 

Phrase: "Preincubation of platelets"

Phrase: "with Zn,"

Phrase: "Cu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1177210:Cu++ [Inorganic Chemical,Pharmacologic Substance]
  1000   C2347872:Cu+ [Element, Ion, or Isotope]

Phrase: "or"

Phrase: "Co"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the cleavage of 22-CTF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "while"

Phrase: "Fe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346593:Fe+++ [Element, Ion, or Isotope]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any inhibitory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.188: Figure 5: Western blot of the 22-CTF degradation in the presence of protease inhibitors, showing that calpeptin and EGTA prevent the disappearance of the 22-CTF and the appearance of the 17-CTF, and inhibit talin degradation. 

Phrase: "Figure 5"

Phrase: ":"

Phrase: "Western blot of the 22-CTF degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   764   C0949466:Western Blot [Laboratory Procedure]
   742   C1705493:Western [Spatial Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of protease inhibitors,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that calpeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the disappearance of the 22-CTF"

Phrase: "and"

Phrase: "the appearance of the 17-CTF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0233426:Appearance [Organism Attribute]
   744   C0700364:Appearance [Qualitative Concept]

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "talin degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.189: Washed platelets were preincubated with the indicated reagents, then treated with A23187. 

Phrase: "Washed platelets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005821:Platelets [Cell]
   861   C1548982:Washed [Idea or Concept]
   861   C1963076:Platelets [Finding]
   827 E C0441648:Wash [Activity]

Phrase: "were"

Phrase: "preincubated with the indicated reagents,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   760   C1444656:Indicated [Finding]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with A23187."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0878412:A23187 [Antibiotic,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.190: Platelets were separated from incubation medium and the platelet lysates were analyzed by Western blot using antibody 369A (panel A) or anti-talin (panel C); 

Phrase: "Platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "separated from incubation medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0086972:Separated [Finding]
   770   C0439536:Medium [Quantitative Concept]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "the platelet lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by Western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody 369A"

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "A)"

Phrase: "or"

Phrase: "anti-talin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420760:TALIN [Gene or Genome]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.191: platelet incubation media were analyzed with 22C11 (panel B). 

Phrase: "platelet incubation media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "analyzed with 22C11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "(panel B"

Phrase: ")."
Processing 00000000.tx.192: ``*'' indicates the new 17-kDa fragment generated upon platelet activation. 

Phrase: "``"

Phrase: "*''"

Phrase: "indicates"

Phrase: "the new 17-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "generated upon platelet activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0032173:Platelet Activation [Organ or Tissue Function]
   770   C0005821:Platelet [Cell]
   770   C1879547:Activation [Activity]
   770   C3146294:Generated [Activity]
Processing 00000000.tx.193: Cal, calpeptin. 

Phrase: "Cal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556156:[Cal] [Quantitative Concept]

Phrase: "calpeptin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.194: The inhibitors calpeptin and EGTA which inhibited the degradation of 22-CTF of APP did not significantly affect the secretion of -granule proteins including APP (Fig. 5B), indicating that platelets under these conditions were physiologically competent and that the processing of the 22-CTF was specifically associated with the calcium influx. 

Phrase: "The inhibitors calpeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "which"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the degradation of 22-CTF of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   792   C1327161:amyloid precursor protein degradation [Molecular Function]
   754   C0597297:Protein Degradation [Molecular Function]
   754   C0597304:Protein Degradation [Molecular Function]
   754   C1623036:Protein Degradation [Molecular Function]
   738   C0243125:degradation [Functional Concept]
   738   C0699900:Degradation [Organism Function]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the secretion of -granule proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(Fig. 5B"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that platelets under these conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005821:Platelets [Cell]
   760   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "physiologically competent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086035:Competent [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the processing of the 22-CTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709694:Processing [Activity]

Phrase: "was"

Phrase: "specifically"

Phrase: "associated with the calcium influx."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.195: Previous studies have shown that the concentration of calpeptin used does not interfere with platelet aggregation and secretion (Fox et al., 1990). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the concentration of calpeptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with platelet aggregation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0032176:Platelet aggregation [Cell Function]
   833   C0677599:Platelet aggregation [Laboratory or Test Result]
   833   C0920267:Platelet Aggregation [Laboratory Procedure]
   770   C0005821:Platelet [Cell]
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
   770   C0521102:Interfere [Qualitative Concept]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "(Fox et al.,"

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.196: However, the inhibitory effect of metal ions (Zn, Cu, or Co) on the 22-CTF degradation may be due in part to their effects on inhibiting platelet activation, since they inhibited the release of both APP and thrombospondin (data not shown). 

Phrase: "However,"

Phrase: "the inhibitory effect of metal ions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(Zn,"

Phrase: "Cu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1177210:Cu++ [Inorganic Chemical,Pharmacologic Substance]
  1000   C2347872:Cu+ [Element, Ion, or Isotope]

Phrase: "or"

Phrase: "Co) on the 22-CTF degradation"

Phrase: "may"

Phrase: "be"

Phrase: "due in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0678226:due [Functional Concept]
   790   C3146286:Due [Idea or Concept]

Phrase: "to their effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "on inhibiting platelet activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0032173:Platelet Activation [Organ or Tissue Function]
   827   C1879547:Activation [Activity]

Phrase: "since"

Phrase: "they"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the release of both APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "thrombospondin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.197: The involvement of a lysosomal or acidic compartment in the cleavage of 22-CTF was also examined. 

Phrase: "The involvement of a lysosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "or"

Phrase: "acidic compartment in the cleavage of 22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1185625:Compartment [Body Space or Junction]
   739   C2986730:Compartment [Spatial Concept]

Phrase: "was"

Phrase: "also"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.198: When whole platelets were preincubated with NHCl, chloroquine, or monensin before the addition of A23187, cleavage of the 22-CTF was not inhibited (). 

Phrase: "When"

Phrase: "whole platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "preincubated with NHCl,"

Phrase: "chloroquine,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   944 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "monensin before the addition of A23187,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0026408:Monensin [Antibiotic,Organic Chemical]

Phrase: "cleavage of the 22-CTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.199: This suggests that the enzymes of lysosomal or acidic compartments were not involved in the degradation of the 22-CTF. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the enzymes of lysosomal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0391845:Lysosomal enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0014442:Enzymes [Enzyme,Organic Chemical]
   770   C0014445:enzymes [Functional Concept]

Phrase: "or"

Phrase: "acidic compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in the degradation of the 22-CTF."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0205088:Terminal [Temporal Concept]
   739   C0243125:degradation [Functional Concept]
   739   C0332255:fragment [Functional Concept]
   739   C0699900:Degradation [Organism Function]
   739   C1314939:Involved [Functional Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.200: We also examined cleavage of other platelet proteins as a result of A23187 treatment. 

Phrase: "We also examined cleavage of other platelet proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0597304:Protein Cleavage [Molecular Function]
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of A23187 treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.201: Talin is an endogenous substrate of calpain and its degradation is used as an index of calpain activity upon platelet activation (Fox et al., 1985, 1990). 

Phrase: "Talin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]

Phrase: "is"

Phrase: "an endogenous substrate of calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "its degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "used as an index of calpain activity"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   778   C1150129:calpain activity [Molecular Function]
   757   C1524063:Use of [Functional Concept]
   748   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0918012:Index [Intellectual Product]
   748   C1273517:used [Finding]
   748   C1552854:index [Idea or Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C1637833:% index [Quantitative Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "upon platelet activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032173:Platelet Activation [Organ or Tissue Function]
   861   C1879547:Activation [Activity]

Phrase: "(Fox et al.,"

Phrase: "1985,"

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.202: Complete cleavage of talin was only observed in the calcium-containing medium, but not in the calcium-free medium (Fig. 4B, lanes 4 and 8), where under the same conditions the disappearance of the 22-CTF of APP and the appearance of the 17-CTF occurred (Fig. 4A). 

Phrase: "Complete cleavage of talin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed in the calcium-containing medium,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0009458:Medium [Intellectual Product]
   753   C0332256:Containing [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1705217:Medium [Substance]
   753   C2700400:Containing [Activity]
   753   C2936886:Calcium [Pharmacologic Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "but"

Phrase: "not in the calcium-free medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   783   C0596235:Free Calcium [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0009458:Medium [Intellectual Product]
   753   C0332296:free [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1518422:Not [Functional Concept]
   753   C1705217:Medium [Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2936886:Calcium [Pharmacologic Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "(Fig. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "lanes 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "8"

Phrase: ")"

Phrase: ","

Phrase: "where under the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0445247:Same [Qualitative Concept]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "the disappearance of the 22-CTF of APP"

Phrase: "and"

Phrase: "the appearance of the 17-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0233426:Appearance [Organism Attribute]
   744   C0700364:Appearance [Qualitative Concept]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.203: A combination of thrombin and collagen treatment or PMA treatment in the presence or absence of calcium resulted in partial degradation of talin (Fig. 4B, lanes 2, 3, 6, and 7), in agreement with previous reports (Fox et al., 1990; Yano et al., 1993), but the cleavage of 22-CTF was not apparent (Fig. 4). 

Phrase: "A combination of thrombin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "collagen treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "PMA treatment in the presence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0039798:treatment [Functional Concept]
   742   C0087111:Treatment [Therapeutic or Preventive Procedure]
   742   C1522326:Treatment [Functional Concept]
   742   C1533734:Treatment [Therapeutic or Preventive Procedure]
   742   C1705169:Treatment [Conceptual Entity]
   742   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "absence of calcium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "resulted in partial degradation of talin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C0728938:Partial [Quantitative Concept]
   753   C1420760:TALIN [Gene or Genome]
   753   C1550516:partial [Idea or Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "(Fig. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "lanes 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6,"

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(Fox et al.,"

Phrase: "1990"

Phrase: "; Yano et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the cleavage of 22-CTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "not apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750489:apparent [Idea or Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.204: In contrast, platelet plasma membrane glycoprotein IIIa and the cytoskeleton protein actin were not cleaved under any of these conditions (data not shown). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "platelet plasma membrane glycoprotein IIIa"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   933   C0245726:Platelet Membrane Glycoprotein IIIa [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Platelet Glycoprotein IIIa
   933   C0638262:Platelet Membrane Glycoprotein IIIa [Amino Acid, Peptide, or Protein,Receptor]
           Platelet Glycoprotein IIIa
   911   C1416498:PLATELET GLYCOPROTEIN IIIa [Gene or Genome]
   722   C0032195:platelet membrane glycoprotein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   708   C0086816:Platelet glycoprotein [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "the cytoskeleton protein actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755 E C0439681:Actinic [Qualitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cleaved under any of these conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205242:Cleaved [Spatial Concept]
   753   C0333853:Cleaved [Cell]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.205: The cleavage of talin was also inhibited by calpeptin, TLCK, E64d, or EGTA (Fig. 5C). 

Phrase: "The cleavage of talin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "also"

Phrase: "inhibited by calpeptin,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "E64d,"

Phrase: "or"

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.206: Digestion of CTF of APP by Purified Calpain The previous results suggested that the cleavage of the 22-CTF was mediated by a calcium-dependent neutral cysteine protease, most of which is composed of calpain in platelets (Phillips and Jakabova, 1977). 

Phrase: "Digestion of CTF of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1523943:protein digestion [Organism Function]
   762   C2349986:Protein Digestion [Research Activity]
           Digestion
   742   C0012238:Digestion [Organism Function]

Phrase: "by Purified Calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "The previous results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the cleavage of the 22-CTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "mediated by a calcium-dependent neutral cysteine protease,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   822   C0006784:Calcium-Dependent Neutral Protease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1882074:Neutral [Qualitative Concept]
   744   C1947941:Protease [Enzyme]
   744   C2825492:Neutral [Phenomenon or Process]
   744   C2936886:Calcium [Pharmacologic Substance]
   744   C3244310:dependent [Functional Concept]

Phrase: "most of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205393:Most [Quantitative Concept]

Phrase: "is"

Phrase: "composed of calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "(Phillips"

Phrase: "and"

Phrase: "Jakabova,"

Phrase: "1977"

Phrase: ")."
Processing 00000000.tx.207: To avoid the problem that some inhibitors may not have been able to penetrate the platelet membrane and interfere with intracellular processing, a platelet lysate was prepared in Tyrode buffer containing 1% Triton X-100 without any added calcium or protease inhibitors. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "the problem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033213:Problem [Finding]

Phrase: "that"

Phrase: "some inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "the platelet membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "interfere with intracellular processing,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C0521102:Interfere [Qualitative Concept]
   770   C1709694:Processing [Activity]

Phrase: "a platelet lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "prepared in Tyrode buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   737   C1521827:Prepare [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Triton X-100 without any added calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   744   C0242759:Triton [Geographic Area]

Phrase: "or"

Phrase: "protease inhibitors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.208: Under these conditions, a 20-CTF of APP was identified in the initial lysate by antibody 369A. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "a 20-CTF of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "identified in the initial lysate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205265:Initial [Temporal Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C1279901:Initial [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1555582:Initial [Idea or Concept]
   760   C1705685:INITIAL [Functional Concept]
   760   C1881488:Lysate [Physical Object]

Phrase: "by antibody 369A."
Processing 00000000.tx.209: From the previous experiments (Fig. 3-5), it was apparent that platelets lysed in the presence of protease inhibitors (leupeptin, PMSF, and EDTA) contained a 22-CTF which disappeared after repeated freeze-thawing of the lysate. 

Phrase: "From the previous experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "(Fig. 3-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]

Phrase: "that platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "lysed in the presence of protease inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   748   C0024348:lysed [Pathologic Function]
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1947941:Protease [Enzyme]
   745 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "EDTA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a 22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "disappeared after repeated freeze-thawing of the lysate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0016701:Freeze [Natural Phenomenon or Process]
   744   C0205341:Repeated [Functional Concept]
   744   C1881488:Lysate [Physical Object]
   711   C1710378:Thaw [Laboratory Procedure]
Processing 00000000.tx.210: This finding suggests that the 22-CTF is a labile intermediate in the APP processing pathway. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the 22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "a labile intermediate in the APP processing pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205103:Intermediate [Spatial Concept]
   739   C1550465:intermediate [Idea or Concept]
   739   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.211: Interestingly, intact talin was not recovered in the lysate prepared without protease inhibitors, suggesting that activation of endogenous calpain due to the lysis procedure was sufficient to cleave the 22-CTF and talin, but not sufficient to produce a 17-CTF of APP. 

Phrase: "Interestingly,"

Phrase: "intact talin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420760:TALIN [Gene or Genome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recovered in the lysate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0521108:recovered [Qualitative Concept]
   770   C1881488:Lysate [Physical Object]
   737 E C2004454:recover [Organism Function]

Phrase: "prepared without protease inhibitors,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   799 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1947941:Protease [Enzyme]
   737   C1521827:Prepare [Functional Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that activation of endogenous calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "due to the lysis procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "cleave"

Phrase: "the 22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "talin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]

Phrase: "but"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "produce"

Phrase: "a 17-CTF of APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.212: To investigate the possibility that calpain may be involved in the degradation of APP fragments, platelet lysates prepared without protease inhibitors were incubated with purified calpain I or II in the presence of 2 mM calcium. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the possibility"

Phrase: "that calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "be"

Phrase: "involved in the degradation of APP fragments,"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   810   C1327161:amyloid precursor protein degradation [Molecular Function]
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0597297:Protein Degradation [Molecular Function]
   762   C0597304:Protein Degradation [Molecular Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1623036:Protein Degradation [Molecular Function]
   748   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243125:degradation [Functional Concept]
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0699900:Degradation [Organism Function]
   742   C1314939:Involved [Functional Concept]
   742   C1709634:Precursor [Idea or Concept]
   708 E C1708096:Fragment [Qualitative Concept]

Phrase: "platelet lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "prepared without protease inhibitors"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   799 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1947941:Protease [Enzyme]
   737   C1521827:Prepare [Functional Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with purified calpain I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1998793:Purified [Functional Concept]

Phrase: "or"

Phrase: "II in the presence of 2 mM calcium."
Processing 00000000.tx.213: On analysis of the APP fragments by Western blotting with antibody 369A, the addition of calpain I resulted in the generation of a 17-CTF, while calpain II did not generate a 17-CTF (Fig. 6, lanes 3 and 4). 

Phrase: "On analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of the APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "fragments by Western blotting"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0332255:fragment [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   770   C1705493:Western [Spatial Concept]
   770   C1708096:Fragment [Qualitative Concept]

Phrase: "with antibody 369A,"

Phrase: "the addition of calpain I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "resulted in the generation of a 17-CTF,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0079411:Generation [Temporal Concept]
   739   C0205088:Terminal [Temporal Concept]
   739   C0332255:fragment [Functional Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1708096:Fragment [Qualitative Concept]
   739   C3146294:Generation [Activity]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "while"

Phrase: "calpain II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006786:Calpain II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "generate"

Phrase: "a 17-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lanes 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.214: The generation of the 17-CTF by calpain I was inhibited by preincubation of the lysate with calpeptin, E64, TLCK, EGTA, or Cu, partially inhibited by Zn, but not by iodoacetamide, DFP, Co, Fe, or pepstatin A (). 

Phrase: "The generation of the 17-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "by calpain I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "inhibited by preincubation of the lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0311403:Inhibited [Qualitative Concept]
   753   C1881488:Lysate [Physical Object]

Phrase: "with calpeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "E64,"

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "or"

Phrase: "Cu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1177210:Cu++ [Inorganic Chemical,Pharmacologic Substance]
  1000   C2347872:Cu+ [Element, Ion, or Isotope]

Phrase: "partially"

Phrase: "inhibited by Zn,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "but"

Phrase: "not by iodoacetamide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1518422:Not [Functional Concept]

Phrase: "DFP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022181:Diisopropyl fluorophosphate [Hazardous or Poisonous Substance,Organophosphorus Compound,Pharmacologic Substance]
   861   C0060567:fluorophosphate [Inorganic Chemical]

Phrase: "Co,"

Phrase: "Fe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346593:Fe+++ [Element, Ion, or Isotope]

Phrase: "or"

Phrase: "pepstatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A ("

Phrase: ")."
Processing 00000000.tx.215: The study of APP processing in cell-free lysate was not possible because there was no detectable APP in the platelet lysates prepared without protease inhibitors, indicating that APP was rapidly degraded upon platelet lysis as previously reported (Li et al., 1994; Schlossmacher et al., 1992). 

Phrase: "The study of APP processing in cell-free lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0557651:Study [Manufactured Object]
   738   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "not possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "because"

Phrase: "there"

Phrase: "was"

Phrase: "no detectable APP in the platelet lysates"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0582509:platelet precursor [Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "prepared without protease inhibitors,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   799 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1947941:Protease [Enzyme]
   737   C1521827:Prepare [Functional Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "indicating"

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded upon platelet lysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005821:Platelet [Cell]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]
   770   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "as"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(Li et al.,"

Phrase: "1994"

Phrase: "; Schlossmacher et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.216: Figure 6: Western blot of calpain digestion of platelet lysates, showing that purified calpain I can produce a 17-CTF. 

Phrase: "Figure 6"

Phrase: ":"

Phrase: "Western blot of calpain digestion of platelet lysates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0949466:Western Blot [Laboratory Procedure]
   744   C1705493:Western [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that purified calpain I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "can"

Phrase: "produce"

Phrase: "a 17-CTF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.217: Platelet lysates were preincubated with the indicated reagents followed by the addition of calpain. 

Phrase: "Platelet lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "preincubated with the indicated reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   760   C1444656:Indicated [Finding]

Phrase: "followed by the addition of calpain."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1883712:Addition [Functional Concept]
   719 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.218: Samples were separated on a 15% SDS-PAGE gel followed by Western blotting using antibody 369A. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "separated on a 15% SDS-PAGE gel"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   818   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   790   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   764   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   764   C0596607:Gel Electrophoresis [Laboratory Procedure]
   762 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   742   C0013855:Electrophoresis [Laboratory Procedure]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   742   C0086972:Separated [Finding]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]
   742   C1382104:Gel [Substance]

Phrase: "followed by Western blotting"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0332283:Followed by [Temporal Concept]
           followed
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody 369A."
Processing 00000000.tx.219: ``*'' indicates the 17-kDa fragment generated by exogenous calpain I. 

Phrase: "``"

Phrase: "*''"

Phrase: "indicates"

Phrase: "the 17-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "generated by exogenous calpain I."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0021966:I- [Inorganic Chemical]
   760   C0205101:Exogenous [Spatial Concept]
   760   C0205228:Exogenous [Functional Concept]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C3146294:Generated [Activity]
Processing 00000000.tx.220: C, platelet lysate without incubation; 

Phrase: "C,"

Phrase: "platelet lysate without incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1881488:Lysate [Physical Object]

Phrase: ";"
Processing 00000000.tx.221: C`: 0.2% MeSO was added to the lysate during incubation. 

Phrase: "C`"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: ":"

Phrase: "0.2% MeSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3641135:MESO [Conceptual Entity]

Phrase: "was"

Phrase: "added to the lysate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1524062:Added [Functional Concept]
   770   C1881488:Lysate [Physical Object]
   737 E C1883712:Add [Functional Concept]

Phrase: "during incubation."
Processing 00000000.tx.222: Cal: calpeptin. 

Phrase: "Cal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556156:[Cal] [Quantitative Concept]

Phrase: ":"

Phrase: "calpeptin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.223: DISCUSSION This study provides evidence that A4 containing CTF of APP and APP are present in platelets and are proteolytically processed following platelet activation. 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that A4 containing CTF of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "are"

Phrase: "present in platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "are"

Phrase: "proteolytically"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "platelet activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032173:Platelet Activation [Organ or Tissue Function]
   861   C1879547:Activation [Activity]
Processing 00000000.tx.224: APP is cleaved when platelets are stimulated by thrombin, collagen, or a combination of both, or by PMA or A23187. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "when"

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "are"

Phrase: "stimulated by thrombin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "collagen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "or"

Phrase: "a combination of both,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "or by PMA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]
   800   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   748   C0031588:phorbol [Organic Chemical]
   748   C0070750:Phorbol [Organic Chemical]
   748   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "or"

Phrase: "A23187."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878412:A23187 [Antibiotic,Organic Chemical]
Processing 00000000.tx.225: Stimulation of platelets by PMA or by a combination of thrombin and collagen leads to the loss of 60-70% of APP. 

Phrase: "Stimulation of platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: "or by a combination of thrombin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "leads to the loss of 60-70% of APP."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0181586:leads [Medical Device]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   738   C1517945:Loss [Quantitative Concept]
   738   C1522538:Lead [Functional Concept]
   738   C1709634:Precursor [Idea or Concept]
   738   C2348269:Lead [Element, Ion, or Isotope]
   738   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.226: In contrast, treatment with A23187 in the presence of calcium induces complete degradation of APP, and induces the generation of two new CTFs of 90-95 kDa identified by 369A, which are not present in PGE, thrombin/collagen, or PMA-treated platelets. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "treatment with A23187"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "complete degradation of APP,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   864   C1327161:amyloid precursor protein degradation [Molecular Function]
   783   C0597297:Protein Degradation [Molecular Function]
   783   C0597304:Protein Degradation [Molecular Function]
   783   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the generation of two new CTFs of 90-95 kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0079411:Generation [Temporal Concept]
   739   C3146294:Generation [Activity]

Phrase: "identified by 369A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "which"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in PGE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0033559:PGE [Biologically Active Substance,Eicosanoid]
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "thrombin/collagen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   861   C1167364:collagen [Cell Component]
   789 E C0439689:Collagenous [Qualitative Concept]

Phrase: "or"

Phrase: "PMA-treated platelets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0005821:Platelets [Cell]
   795   C1963076:Platelets [Finding]
Processing 00000000.tx.227: This indicates that the APP can be cleaved in the NH-terminal extracellular domain. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that"

Phrase: "the APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "cleaved in the NH-terminal extracellular domain."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1517050:Extracellular Domain [Spatial Concept]
   748   C0205088:Terminal [Temporal Concept]
   748   C0205242:Cleaved [Spatial Concept]
   748   C0268059:NH [Disease or Syndrome]
   748   C0333853:Cleaved [Cell]
   748   C0521119:Extracellular [Cell Component]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.228: It is not clear whether the degradation of APP produces any large NH-terminal fragments (by cleavage at the COOH-terminal side), since it is difficult to differentiate any newly generated NH-terminal fragments from the existing sAPP species (e.g. APP, APP) in PGE-treated platelets. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "the degradation of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   864   C1327161:amyloid precursor protein degradation [Molecular Function]
   783   C0597297:Protein Degradation [Molecular Function]
   783   C0597304:Protein Degradation [Molecular Function]
   783   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "produces"

Phrase: "any large NH-terminal fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "by cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "at the COOH-terminal side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441987:Side [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "since"

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "differentiate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiate [Qualitative Concept]

Phrase: "any newly generated NH-terminal fragments from the existing sAPP species"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C0332255:fragments [Functional Concept]
   738   C0486805:Fragments [Body Substance]
   704 E C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "e.g. APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "in PGE-treated platelets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005821:Platelets [Cell]
   827   C1963076:Platelets [Finding]
Processing 00000000.tx.229: The cleavage of APP is partially inhibited by cysteine protease inhibitors, calpeptin, TLCK, E64d, or the calcium chelator EGTA, but not inhibited by serine, metallo, or aspartic protease inhibitors (DFP, PMSF, phosphoramidon, 1,10-phenanthroline, or pepstatin) and acidic compartment inhibitors (monensin, chloroquine, or NHCl). 

Phrase: "The cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "partially"

Phrase: "inhibited by cysteine protease inhibitors,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   862   C0010658:Cysteine Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   806   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   806   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   806   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   773 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1947941:Protease [Enzyme]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "calpeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "E64d,"

Phrase: "or"

Phrase: "the calcium chelator EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited by serine,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "metallo,"

Phrase: "or"

Phrase: "aspartic protease inhibitors"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   901   C2717969:Aspartic Protease [Amino Acid, Peptide, or Protein,Enzyme]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(DFP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022181:Diisopropyl fluorophosphate [Hazardous or Poisonous Substance,Organophosphorus Compound,Pharmacologic Substance]
   861   C0060567:fluorophosphate [Inorganic Chemical]

Phrase: "PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "or"

Phrase: "pepstatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "acidic compartment inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(monensin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026408:Monensin [Antibiotic,Organic Chemical]

Phrase: "chloroquine,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   944 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "NHCl"

Phrase: ")."
Processing 00000000.tx.230: Although metal ions (Zn, Cu, and Co) inhibit APP degradation, this may be due to complex effects on the physiological function of platelets, since these ions affect the secretion of platelet -granule contents, including APP and thrombospondin.() A 22-kDa polypeptide was found in platelets which reacts with a variety of antibodies to the A4 and COOH-terminal region of APP, including 6E10 and 369A. 

Phrase: "Although"

Phrase: "metal ions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "(Zn,"

Phrase: "Cu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1177210:Cu++ [Inorganic Chemical,Pharmacologic Substance]
  1000   C2347872:Cu+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Co)"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "APP degradation,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "this"

Phrase: "may"

Phrase: "be due to complex effects"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0439855:Complex [Qualitative Concept]
   760   C1280500:effects [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the physiological function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "of platelets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "since"

Phrase: "these ions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022023:Ions [Element, Ion, or Isotope]
   966 E C1700702:ION [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the secretion of platelet -granule contents,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0544610:Platelet secretion [Organ or Tissue Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "thrombospondin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076560:Thrombospondin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: ")"

Phrase: "A 22-kDa polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "found in platelets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0005821:Platelets [Cell]
   790   C0150312:Found [Quantitative Concept]
   790   C1963076:Platelets [Finding]
   756 E C0243095:Find [Finding]

Phrase: "which"

Phrase: "reacts with a variety of antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to the A4"

Phrase: "and"

Phrase: "COOH-terminal region of APP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1514562:Protein Region [Amino Acid Sequence]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "6E10"

Phrase: "and"

Phrase: "369A."
Processing 00000000.tx.231: This indicates that the 22-CTF contains the A4 sequence, and is therefore derived from APP, rather than from the related molecules APLP1 and APLP2 (Sprecher et al., 1993; Wasco et al., 1992), and also is potentially amyloidogenic. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that"

Phrase: "the 22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the A4 sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "therefore"

Phrase: "derived from APP,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1441547:Derived [Qualitative Concept]
   760   C1709634:Precursor [Idea or Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "rather than from the related molecules APLP1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C0567416:molecules [Substance]
   748   C1412466:APLP1 [Gene or Genome]

Phrase: "and"

Phrase: "APLP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: "(Sprecher et al.,"

Phrase: "1993"

Phrase: "; Wasco et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "also"

Phrase: "is"

Phrase: "potentially amyloidogenic."
Processing 00000000.tx.232: Because the 22-CTF is present in resting platelets, it is likely to have been produced by a normal processing event. 

Phrase: "Because"

Phrase: "the 22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "present in resting platelets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "produced by a normal processing event."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C0441471:Event [Event]
   753   C1709694:Processing [Activity]
   753   C2347086:% Normal [Quantitative Concept]
   719 E C1184743:Process [Body Part, Organ, or Organ Component]
   719 E C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.233: Previous studies have also identified APP CTFs in platelets and lymphoblastoid cells in familial Alzheimer's disease (Ghiso et al., 1994; Matsumoto and Fujiwara, 1993). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also identified APP CTFs in platelets"

Phrase: "and"

Phrase: "lymphoblastoid cells in familial Alzheimer's disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Ghiso et al.,"

Phrase: "1994"

Phrase: "; Matsumoto"

Phrase: "and"

Phrase: "Fujiwara,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.234: In both studies, the NH terminus of the CTF was found to begin 30 residues NH-terminal to the A4 sequence. 

Phrase: "In both studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "the NH terminus of the CTF"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "30 residues NH-terminal to the A4 sequence."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205088:Terminal [Temporal Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.235: By immunoreactivity with specific antibodies, a 22-kDa APP fragment containing the A4 epitope was also found in transfected 293 cells, brain microvessels, and human umbilical vein endothelial cells (Haass et al., 1992; Knops et al., 1992; Tamaoka et al., 1992). 

Phrase: "By immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "with specific antibodies,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "a 22-kDa APP fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the A4 epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "was"

Phrase: "also"

Phrase: "found in transfected 293 cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0150312:Found [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C0243095:Find [Finding]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "brain microvessels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2350570:Microvessels [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "human umbilical vein endothelial cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Haass et al.,"

Phrase: "1992"

Phrase: "; Knops et al.,"

Phrase: "1992"

Phrase: "; Tamaoka et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.236: When platelets were treated with A23187 plus calcium, the 22-CTF was not detected. 

Phrase: "When"

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "treated with A23187 plus calcium,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0332287:Plus [Qualitative Concept]
   760   C0878412:A23187 [Antibiotic,Organic Chemical]
   760   C1522326:Treated [Functional Concept]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "the 22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.237: Concomitant with the loss of the 22-CTF, there was the appearance of a 17-CTF. 

Phrase: "Concomitant with the loss of the 22-CTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0521115:Concomitant [Temporal Concept]

Phrase: "there"

Phrase: "was"

Phrase: "the appearance of a 17-CTF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0233426:Appearance [Organism Attribute]
   744   C0700364:Appearance [Qualitative Concept]
Processing 00000000.tx.238: This 17-CTF did not react with mAb 6E10 (which recognizes A4), indicating that the NH terminus of A4 may have been removed with the loss of this epitope. 

Phrase: "This 17-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "react with mAb 6E10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]

Phrase: "("

Phrase: "which"

Phrase: "recognizes"

Phrase: "A4"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the NH terminus of A4"

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "removed with the loss of this epitope."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0003316:Epitope [Immunologic Factor]
   748   C0849355:Removed [Qualitative Concept]
   748   C1517945:Loss [Quantitative Concept]
   714 E C1883720:Remove [Activity]
   714 E C3244314:remove [Functional Concept]
Processing 00000000.tx.239: Since the 17-CTF band reacts more strongly with antibody 369A than the 22-CTF band, this suggests that larger fragments (including APP) could also be the precursors of the 17-CTF. 

Phrase: "Since"

Phrase: "the 17-CTF band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0175723:Band [Medical Device]
   804   C0439645:Band [Spatial Concept]
   804   C1521913:band [Cell Component]

Phrase: "reacts"

Phrase: "more strongly with antibody 369A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205172:More [Functional Concept]

Phrase: "than the 22-CTF band,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0175723:Band [Medical Device]
   804   C0439645:Band [Spatial Concept]
   804   C1521913:band [Cell Component]

Phrase: "this"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that larger fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "the precursors of the 17-CTF."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.240: Low levels of 22-CTF cleavage and 17-CTF production in thrombin/collagen-treated platelets may occur, but this may be beyond the sensitivity of the Western blotting detection used in this study. 

Phrase: "Low levels of 22-CTF cleavage"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "17-CTF production in thrombin/collagen-treated platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0221145:Platelet production [Cell Function]
   739   C0033268:production [Occupational Activity]

Phrase: "may"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "but"

Phrase: "this"

Phrase: "may"

Phrase: "be beyond the sensitivity of the Western blotting detection"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   764   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   748 E C0949466:Western Blot [Laboratory Procedure]
   742   C0036667:Sensitivity [Quantitative Concept]
   742   C0312418:Sensitivity [Mental Process]
   742   C0427965:Sensitivity [Finding]
   742   C1511790:Detection [Therapeutic or Preventive Procedure]
   742   C1511883:Sensitivity [Quantitative Concept]
   742   C1522640:Sensitivity [Qualitative Concept]
   742   C1705493:Western [Spatial Concept]
   742   C2346484:SENSITIVITY [Phenomenon or Process]
   742   C2349185:Sensitivity [Qualitative Concept]
   742   C2987476:Be [Conceptual Entity]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.241: The cleavage of 22-CTF is also inhibited by calpeptin, TLCK, E64d, the calcium chelator EGTA, or metal ions (Zn, Cu, Co), but not by serine, metallo, or aspartic protease inhibitors, and not by reagents that affect the acidic compartment and lysosomes. 

Phrase: "The cleavage of 22-CTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "also"

Phrase: "inhibited by calpeptin,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "E64d,"

Phrase: "the calcium chelator EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "or"

Phrase: "metal ions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "(Zn,"

Phrase: "Cu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1177210:Cu++ [Inorganic Chemical,Pharmacologic Substance]
  1000   C2347872:Cu+ [Element, Ion, or Isotope]

Phrase: "Co"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not by serine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1518422:Not [Functional Concept]

Phrase: "metallo,"

Phrase: "or"

Phrase: "aspartic protease inhibitors,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   901   C2717969:Aspartic Protease [Amino Acid, Peptide, or Protein,Enzyme]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "not by reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   790   C1518422:Not [Functional Concept]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the acidic compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "and"

Phrase: "lysosomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]
Processing 00000000.tx.242: The protease responsible for the degradation of APP and 22-CTF in the stimulated platelets remains to be identified. 

Phrase: "The protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "responsible for the degradation of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "22-CTF in the stimulated platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.243: The characteristics of inhibition of degradation of APP and 22-CTF are consistent with the involvement of a calcium-dependent neutral cysteine protease, since degradation of APP and 22-CTF occurred at neutral pH and was inhibited by cysteine protease inhibitors (calpeptin, TLCK, E64d), and the calcium chelator EGTA. 

Phrase: "The characteristics of inhibition of degradation of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "consistent with the involvement of a calcium-dependent neutral cysteine protease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "since"

Phrase: "degradation of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   900   C1327161:amyloid precursor protein degradation [Molecular Function]
   797   C0597297:Protein Degradation [Molecular Function]
   797   C0597304:Protein Degradation [Molecular Function]
   797   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "22-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "occurred at neutral pH"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1709305:Occurred [Activity]
   770   C2825492:Neutral [Phenomenon or Process]
   737 E C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "was"

Phrase: "inhibited by cysteine protease inhibitors"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   862   C0010658:Cysteine Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   806   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   806   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   806   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   773 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1947941:Protease [Enzyme]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(calpeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "E64d"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the calcium chelator EGTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.244: Calpeptin inhibits a number of cysteine proteases (Tsujinaka et al., 1988; Sasaki et al., 1990) and is widely used for studying the function of platelet calpain which constitutes most of the calcium-dependent protease activity in platelets (Ariyoshi et al., 1991; Fox et al., 1990; Oda et al., 1993). 

Phrase: "Calpeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "a number of cysteine proteases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(Tsujinaka et al.,"

Phrase: "1988"

Phrase: "; Sasaki et al.,"

Phrase: "1990"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "widely"

Phrase: "used for studying"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   824   C0869040:study use [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756   C0557651:Study [Manufactured Object]
   756 E C1947944:Use [Intellectual Product]
   756   C2603343:Study [Research Activity]

Phrase: "the function of platelet calpain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0920267:Platelet Function [Laboratory Procedure]
   797   C1254881:Platelet function [Cell Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "which"

Phrase: "constitutes"

Phrase: "most of the calcium-dependent protease activity"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C1150095:protease activity [Molecular Function]
   748   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0006726:Calcium [Inorganic Chemical]
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0205393:Most [Quantitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C1947941:Protease [Enzyme]
   748   C2936886:Calcium [Pharmacologic Substance]
   748   C3244310:dependent [Functional Concept]

Phrase: "in platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "(Ariyoshi et al.,"

Phrase: "1991"

Phrase: "; Fox et al.,"

Phrase: "1990"

Phrase: "; Oda et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.245: Calpeptin is known to inhibit lysosomal cathepsin B as well as calpain (Sasaki et al., 1990). 

Phrase: "Calpeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "lysosomal cathepsin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332804:CATHEPSIN B [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as well as"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Sasaki et al.,"

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.246: However, cathepsin B is most active under acidic conditions and does not require calcium. 

Phrase: "However,"

Phrase: "cathepsin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "most active under acidic conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "calcium."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.247: Involvement of cathepsin B in the platelet APP degradation is unlikely, since the platelet APP degradation was not affected by NHCl and chloroquine. 

Phrase: "Involvement of cathepsin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "in the platelet APP degradation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C1327161:amyloid precursor protein degradation [Molecular Function]
   840   C0597297:Protein Degradation [Molecular Function]
   840   C0597304:Protein Degradation [Molecular Function]
   840   C1623036:Protein Degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "is"

Phrase: "unlikely,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "since"

Phrase: "the platelet APP degradation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C1327161:amyloid precursor protein degradation [Molecular Function]
   840   C0597297:Protein Degradation [Molecular Function]
   840   C0597304:Protein Degradation [Molecular Function]
   840   C1623036:Protein Degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by NHCl"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "chloroquine."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   944 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.248: Addition of purified calpain to the platelet lysate generated a 17-CTF, similar to that found in the A23187-treated platelets. 

Phrase: "Addition of purified calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "to the platelet lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881488:Lysate [Physical Object]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a 17-CTF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "found in the A23187-treated platelets."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0005821:Platelets [Cell]
   753   C0150312:Found [Quantitative Concept]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C0878412:A23187 [Antibiotic,Organic Chemical]
   753   C1522326:Treated [Functional Concept]
   753   C1963076:Platelets [Finding]
   719 E C0243095:Find [Finding]
   719 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.249: The generation of the 17-CTF was also inhibited by calpeptin, E64, TLCK, and EGTA. 

Phrase: "The generation of the 17-CTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "was"

Phrase: "also"

Phrase: "inhibited by calpeptin,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "E64,"

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "and"

Phrase: "EGTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.250: Taken together our data suggest that a calcium-dependent mechanism involving a neutral cysteine protease with characteristics similar to calpain participates in the degradation of APP and 22-CTF. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a calcium-dependent mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "a neutral cysteine protease with characteristics"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   790   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1947941:Protease [Enzyme]

Phrase: "similar to calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "participates in the degradation of APP"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   822   C1327161:amyloid precursor protein degradation [Molecular Function]
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0597297:Protein Degradation [Molecular Function]
   767   C0597304:Protein Degradation [Molecular Function]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C1623036:Protein Degradation [Molecular Function]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243125:degradation [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0699900:Degradation [Organism Function]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "22-CTF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.251: However, the involvement of other proteases in APP degradation seems likely. 

Phrase: "However,"

Phrase: "the involvement of other proteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in APP degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "seems"

Phrase: "likely."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]
Processing 00000000.tx.252: Since APP is membrane-associated (Li et al., 1994), it could be expected that the proteolytic activity (a calcium-dependent neutral cysteine protease) involved in APP processing also co-localizes to membranes. 

Phrase: "Since"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "membrane-associated"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0025255:Membrane [Tissue]
   861   C0332281:Associated [Qualitative Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   827 E C0750490:Associate [Idea or Concept]
   827 E C1706221:Associate [Professional or Occupational Group]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Li et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "that"

Phrase: "the proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C0597304:Proteolytic [Molecular Function]
   861   C1561536:*Activity [Idea or Concept]
   861   C1947941:proteolytic [Enzyme]

Phrase: "("

Phrase: "a calcium-dependent neutral cysteine protease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   933   C0006784:Calcium-Dependent Neutral Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1947941:Protease [Enzyme]

Phrase: ")"

Phrase: "involved in APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1314939:Involved [Functional Concept]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "processing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]
   966 E C1522240:Process [Phenomenon or Process]

Phrase: "also"

Phrase: "co-localizes to membranes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0025255:Membranes [Tissue]
   770   C0392752:localize [Spatial Concept]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.253: The main calcium-dependent neutral cysteine protease in platelets is calpain and it is usually located intracellularly in the cytoplasm or associated with membrane (Saido et al., 1993, 1994). 

Phrase: "The main calcium-dependent neutral cysteine protease in platelets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   810   C0006784:Calcium-Dependent Neutral Protease [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   764   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C1947941:Protease [Enzyme]

Phrase: "is"

Phrase: "calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "usually"

Phrase: "located"

Phrase: "intracellularly in the cytoplasm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010834:Cytoplasm [Cell Component]

Phrase: "or"

Phrase: "associated with membrane"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0025255:Membrane [Tissue]
   790   C0596901:Membrane [Cell Component]
   790   C1706182:Membrane [Manufactured Object]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Saido et al.,"

Phrase: "1993,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.254: Our results confirm the presence of a calcium-dependent neutral cysteine protease activity (calpeptin and EGTA sensitive) inside platelets which degrades talin. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of a calcium-dependent neutral cysteine protease activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(calpeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332324:Sensitive [Functional Concept]
  1000   C1550474:sensitive [Idea or Concept]

Phrase: ")"

Phrase: "inside platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "which"

Phrase: "degrades"

Phrase: "talin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085182:Talin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420760:TALIN [Gene or Genome]
Processing 00000000.tx.255: This activity would correspond to the previously described calpain activity (Fox et al., 1985, 1990; Yano et al., 1993). 

Phrase: "This activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "would"

Phrase: "correspond to the previously described calpain activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1150129:calpain activity [Molecular Function]
   748   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1552738:described [Idea or Concept]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "(Fox et al.,"

Phrase: "1985,"

Phrase: "1990"

Phrase: "; Yano et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.256: We could also demonstrate an activity resembling calcium-dependent neutral cysteine protease outside platelets by studying the release of GPIb (the receptor for von Willebrand factor). 

Phrase: "We"

Phrase: "could"

Phrase: "also"

Phrase: "demonstrate"

Phrase: "an activity resembling calcium-dependent neutral cysteine protease outside platelets by studying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0005821:Platelets [Cell]
   736   C1963076:Platelets [Finding]

Phrase: "the release of GPIb"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "the receptor for von Willebrand factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   864   C0078411:von Willebrand factor receptor [Amino Acid, Peptide, or Protein,Receptor]
   820   C0312498:von Willebrand receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")."
Processing 00000000.tx.257: Increased amounts of GC were detected in the medium as a result of platelet activation, and this process was partially inhibited by calpeptin, TLCK, E64d, or EGTA. 

Phrase: "Increased amounts of GC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "detected in the medium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of platelet activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032173:Platelet Activation [Organ or Tissue Function]
   861   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "partially"

Phrase: "inhibited by calpeptin,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0108192:calpeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "E64d,"

Phrase: "or"

Phrase: "EGTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.258: This is consistent with the finding that GPIb is cleaved by a cysteine protease (calpain) within the extracellular juxta-membranous segment to release GC (McGowan et al., 1983; Yoshida et al., 1983). 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   783   C0332529:Consistency finding [Qualitative Concept]

Phrase: "that GPIb"

Phrase: "is"

Phrase: "cleaved by a cysteine protease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   806   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]
   760   C1947941:Protease [Enzyme]

Phrase: "(calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "within the extracellular juxta-membranous segment to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0441635:Segment [Spatial Concept]
   733 E C0205122:Segmental [Spatial Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "GC (McGowan et al.,"

Phrase: "1983"

Phrase: "; Yoshida et al.,"

Phrase: "1983"

Phrase: ")."
Processing 00000000.tx.259: The activity which cleaves GPIb therefore shares similar characteristics with the one that processes APP. 

Phrase: "The activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "cleaves"

Phrase: "GPIb therefore"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "similar characteristics with the one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "that processes APP."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   886   C0033666:process protein [Molecular Function]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.260: Whether cleavage of APP and GPIb involves the same or different calcium-activated neutral cysteine proteases remained to be determined. 

Phrase: "Whether"

Phrase: "cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597304:Protein Cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "GPIb"

Phrase: "involves"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "or"

Phrase: "different calcium-activated neutral cysteine proteases"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   892   C0006784:Calcium-Activated Neutral Protease [Amino Acid, Peptide, or Protein,Enzyme]
           Calcium-Activated Protease
   827   C2717970:Cysteine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   810 E C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   810 E C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   799   C1947941:Proteases [Enzyme]

Phrase: "remained"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.261: Other studies support our view that calcium is involved in the regulation of APP processing. 

Phrase: "Other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our"

Phrase: "view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "is"

Phrase: "involved in the regulation of APP processing."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   807   C2753370:regulation of protein processing [Genetic Function]
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0033666:protein processing [Molecular Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1314939:Involved [Functional Concept]
   742   C1327622:Regulation [Biologic Function]
   742   C1709634:Precursor [Idea or Concept]
   742   C1709694:Processing [Activity]
Processing 00000000.tx.262: Buxbaum et al.(1994) showed that APP processing is regulated by intracellular calcium levels, independent of regulation by protein kinase C activation. 

Phrase: "Buxbaum et al.(1994"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "regulated by intracellular calcium levels,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0201925:calcium levels [Laboratory Procedure]
   806   C0428302:calcium levels [Laboratory or Test Result]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "independent of regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "by protein kinase C activation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C3546691:protein kinase C activation [Molecular Function]
   923   C1819041:protein kinase activation [Cell Function]
   902   C0599177:protein activation [Genetic Function]
   812   C1879547:Activation [Activity]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.263: Calcium might also be involved in the amyloidogenic processing of APP (Mattson et al., 1992; Peterson et al., 1986; 1991; Saito et al., 1993). 

Phrase: "Calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "involved in the amyloidogenic processing of APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0033666:protein processing [Molecular Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1314939:Involved [Functional Concept]
   742   C1709634:Precursor [Idea or Concept]
   742   C1709694:Processing [Activity]

Phrase: "(Mattson et al.,"

Phrase: "1992"

Phrase: "; Peterson et al.,"

Phrase: "1986"

Phrase: "; 1991"

Phrase: "; Saito et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.264: Increasing intracellular calcium levels with A23187 mediates a 3-fold increase in production of A4 in human kidney 293 cells transfected with APP (Querfurth and Selkoe, 1994). 

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "intracellular calcium levels with A23187"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0201925:calcium levels [Laboratory Procedure]
   806   C0428302:calcium levels [Laboratory or Test Result]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "a 3-fold increase in production of A4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "in human kidney 293 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "(Querfurth"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.265: An increase in the activated form of calpain is found in Alzheimer's disease brain regions where neurons are most affected (Nilsson et al., 1990; Saito et al., 1993). 

Phrase: "An increase in the activated form of calpain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "found in Alzheimer's disease brain regions where neurons"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1273723:brain regions [Body Location or Region]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0006111:Brain Disease [Disease or Syndrome]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0027882:Neurons [Cell]
   744   C0150312:Found [Quantitative Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   725   C1514819:Regional Disease [Finding]
   711   C0017446:Region [Geographic Area]
   711   C0205147:Region [Spatial Concept]
   711 E C0243095:Find [Finding]

Phrase: "are"

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "(Nilsson et al.,"

Phrase: "1990"

Phrase: "; Saito et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.266: Although we have been unable to demonstrate any qualitative differences between Alzheimer's disease and control platelets in their Ca-activated processing of APP,() the possibility remains that a chronic disturbance of calcium homeostasis in neurons (especially if caused by the toxicity of the A4 protein itself) (Furukawa et al., 1994) might perturb a calpain-like enzyme mediated cleavage of APP. 

Phrase: "Although"

Phrase: "we"

Phrase: "have"

Phrase: "been"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "demonstrate"

Phrase: "any qualitative differences between Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "control platelets in their Ca-activated processing of APP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0005821:Platelets [Cell]
   738   C1963076:Platelets [Finding]
   737   C0491336:CONTROL, PLATELET [Indicator, Reagent, or Diagnostic Aid]
   737   C0582509:platelet precursor [Biologically Active Substance]

Phrase: "("

Phrase: ")"

Phrase: "the possibility"

Phrase: "remains"

Phrase: "that"

Phrase: "a chronic disturbance of calcium homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2699787:Disturbance [Qualitative Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(especially"

Phrase: "if"

Phrase: "caused by the toxicity of the A4 protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040539:toxicity [Qualitative Concept]
   744   C0600688:Toxicity [Injury or Poisoning]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]

Phrase: "itself"

Phrase: ")"

Phrase: "(Furukawa et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: "might"

Phrase: "perturb"

Phrase: "a calpain-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "cleavage of APP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597304:Protein Cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
Processing 00000000.tx.267: This may modulate a cycle of calcium-mediated APP processing, and thereby affect an amyloidogenic pathway contributing to the evolution of Alzheimer's disease.  

Phrase: "This"

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "a cycle of calcium-mediated APP processing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "an amyloidogenic pathway contributing to the evolution of Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880177:Contributing [Activity]
Processing 00000000.tx.268: Table: Effect of various protease inhibitors, acidic compartment inhibitors, and metal ions on the cleavage of 22-CTF and APP in stimulated platelets The platelets were preincubated with the reagents for 15 min at room temperature and activated with A23187 (1 M). 

Phrase: "Table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "Effect of various protease inhibitors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "acidic compartment inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "metal ions on the cleavage of 22-CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   741   C1708097:Fragment Ion [Element, Ion, or Isotope]
   739   C0022023:Ions [Element, Ion, or Isotope]
   706 E C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "APP in stimulated platelets"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0582509:platelet precursor [Biologically Active Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "The platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "were"

Phrase: "preincubated with the reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "activated with A23187"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0878412:A23187 [Antibiotic,Organic Chemical]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M)."
Processing 00000000.tx.269: The samples were analyzed by Western blotting as described under ``Materials and Methods.'' 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "as"

Phrase: "described under ``Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods.''"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.270: The final concentrations of inhibitors are shown. 

Phrase: "The final concentrations of inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.271: ``+'' indicates that the cleavage of substrate was inhibited or that product was formed, ``+/-'' indicates partial inhibition, and ``-'' indicates lack of inhibition of substrate cleavage or no product formation. 

Phrase: "``+''"

Phrase: "indicates"

Phrase: "that"

Phrase: "the cleavage of substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "or"

Phrase: "that product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ","

Phrase: "``+/-''"

Phrase: "indicates"

Phrase: "partial inhibition,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and ``-''"

Phrase: "indicates"

Phrase: "lack of inhibition of substrate cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "or"

Phrase: "no product formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.272: Numerical values are not assigned as these were not quantitative assays.  

Phrase: "Numerical values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C1522609:Numerical value [Quantitative Concept]
       E   Value
   861   C0042295:Values [Qualitative Concept]
   861   C0237753:Numerical [Quantitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "assigned as these"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516050:Assigned [Functional Concept]
   790   C1552601:assigned [Intellectual Product]

Phrase: "were"

Phrase: "not quantitative assays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0392762:Quantitative [Quantitative Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.273: Table: Effects of various protease inhibitors and metal ions on the generation of the 17-CTF by calpain I in platelet lysates Platelet lysates were preincubated with the indicated reagents followed by addition of calpain I and analyzed by Western blotting as described in the ``Materials and Methods.'' 

Phrase: "Table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "Effects of various protease inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "metal ions on the generation of the 17-CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C0022023:Ions [Element, Ion, or Isotope]
   737   C1708097:Fragment Ion [Element, Ion, or Isotope]
   704 E C1700702:ION [Functional Concept]

Phrase: "by calpain I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in platelet lysates Platelet lysates"

Phrase: "were"

Phrase: "preincubated with the indicated reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   760   C1444656:Indicated [Finding]

Phrase: "followed by addition of calpain I"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1883712:Addition [Functional Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "as"

Phrase: "described in the ``Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520510:Materials [Substance]
   770   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods.''"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.274: ``+'' indicates the 17-CTF product was detected, and ``-'' indicates lack of product formation, ``+/-'' indicates that a small amount of the 17-CTF product was detected compared to the control with protease alone. 

Phrase: "``+''"

Phrase: "indicates"

Phrase: "the 17-CTF product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "and ``-''"

Phrase: "indicates"

Phrase: "lack of product formation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "``+/-''"

Phrase: "indicates"

Phrase: "that"

Phrase: "a small amount of the 17-CTF product"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "compared to the control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "with protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.275: Numerical values are not assigned as this was not a quantitative assay. 

Phrase: "Numerical values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C1522609:Numerical value [Quantitative Concept]
       E   Value
   861   C0042295:Values [Qualitative Concept]
   861   C0237753:Numerical [Quantitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "assigned as this"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516050:Assigned [Functional Concept]
   790   C1552601:assigned [Intellectual Product]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a quantitative assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.276: FOOTNOTES * This work was supported in part by grants from the National Health and Medical Research Council of Australia, the Aluminium Development Council of Australia, and the Victorian Health Promotion Foundation. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by grants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018173:Grants [Quantitative Concept]
   966 E C1548284:Grant [Idea or Concept]

Phrase: "from the National Health and Medical Research Council"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   904   C0027472:National Research Council [Organization]
   827   C0079816:Medical Research [Research Activity]
   827   C1556038:Medical Research [Professional or Occupational Group]
   799   C0018684:Health [Idea or Concept]
   799   C0035168:research [Research Activity]
   799   C0205476:Medical [Functional Concept]
   799   C0242481:Research [Research Activity]
   799   C1551807:Council [Population Group]
   799   C3245503:national [Intellectual Product]

Phrase: "of Australia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: "the Aluminium Development Council of Australia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1551807:Council [Population Group]

Phrase: "and"

Phrase: "the Victorian Health Promotion Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.277: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.278: This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore by hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "``advertisement''"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.279: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.280: Supported by the Deutsche Forschungsgemeinschaft and the Bundesministerium fr Forschung und Technologie.  

Phrase: "Supported by the Deutsche Forschungsgemeinschaft"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "the Bundesministerium fr Forschung und Technologie."
Processing 00000000.tx.281: To whom correspondence should be addressed: Dept. of Pathology, The University of Melbourne, Parkville, Victoria, 3052 Australia. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "The University of Melbourne,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Parkville,"

Phrase: "Victoria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042645:Victoria [Geographic Area]
  1000   C0997115:Victoria [Plant]

Phrase: "3052 Australia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004340:Australia [Geographic Area]
   789 E C0238711:AUSTRALIAN [Finding]
Processing 00000000.tx.282: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.283: 61-3-344-5868; 

Phrase: "61-3-344-5868"

Phrase: ";"
Processing 00000000.tx.284: Fax: 61-3-344-4004. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "61-3-344-4004."
Processing 00000000.tx.285: The abbreviations used are: APP, amyloid precursor protein; 

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.286: A4, the APP amyloid cleavage product; 

Phrase: "A4,"

Phrase: "the APP amyloid cleavage product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C0597304:Protein Cleavage [Molecular Function]
   799   C0010813:cleavage [Cell Function]
   799   C0596311:Cleavage [Phenomenon or Process]
   799   C1330957:cleavage [Cell Function]
   799   C1514468:product [Entity]
   799   C1704444:Product [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.287: CTF, COOH-terminal fragment; 

Phrase: "CTF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "COOH-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.288: APP, full-length APP; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.289: sAPP, secreted APP; 

Phrase: "sAPP,"

Phrase: "secreted APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1327616:Secreted [Cell Function]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.290: APP, secreted APP product generated by -secretase; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "secreted APP product"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "generated by -secretase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C3146294:Generated [Activity]

Phrase: ";"
Processing 00000000.tx.291: APP, secreted APP product generated by -secretase; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "secreted APP product"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "generated by -secretase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C3146294:Generated [Activity]

Phrase: ";"
Processing 00000000.tx.292: PGE, prostaglandin E; 

Phrase: "PGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033559:PGE [Biologically Active Substance,Eicosanoid]

Phrase: "prostaglandin E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033559:Prostaglandin E [Biologically Active Substance,Eicosanoid]
   861   C0033554:Prostaglandin [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   861   C1266240:Prostaglandin [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.293: PMA, phorbol 12-myristate 13-acetate; 

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: "phorbol 12-myristate 13-acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.294: E64, trans-epoxysuccinyl-L-leucylamido-(4-guanidino)-butane; 

Phrase: "E64,"

Phrase: "trans-epoxysuccinyl-L-leucylamido-"

Phrase: "(4-guanidino"

Phrase: ")-"

Phrase: "butane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006474:Butane [Organic Chemical,Pharmacologic Substance]
  1000   C0006476:butane [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.295: E64d, (2S,3S)-trans-epoxysuccinyl-L-leucyl-amido-3-methylbutane ethylester; 

Phrase: "E64d,"

Phrase: "(2S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552116:2s [Body Part, Organ, or Organ Component]

Phrase: "3S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552117:3s [Body Part, Organ, or Organ Component]

Phrase: ")-"

Phrase: "trans-epoxysuccinyl-L-leucyl-amido-3-methylbutane ethylester"

Phrase: ";"
Processing 00000000.tx.296: TLCK, Na-p-tosyl-L-lysine chloromethyl ketone; 

Phrase: "TLCK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0022634:Ketone [Organic Chemical]

Phrase: "Na-p-tosyl-L-lysine chloromethyl ketone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0604331:lysine chloromethyl ketone [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0022634:Ketone [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.297: TPCK, N-tosyl-L-phenylalanine chloromethyl ketone; 

Phrase: "TPCK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0022634:Ketone [Organic Chemical]

Phrase: "N-tosyl-L-phenylalanine chloromethyl ketone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0022634:Ketone [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.298: DFP, diisopropyl fluorophosphate; 

Phrase: "DFP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022181:Diisopropyl fluorophosphate [Hazardous or Poisonous Substance,Organophosphorus Compound,Pharmacologic Substance]
   861   C0060567:fluorophosphate [Inorganic Chemical]

Phrase: "diisopropyl fluorophosphate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022181:Diisopropyl fluorophosphate [Hazardous or Poisonous Substance,Organophosphorus Compound,Pharmacologic Substance]
   861   C0060567:fluorophosphate [Inorganic Chemical]

Phrase: ";"
Processing 00000000.tx.299: PMSF, phenylmethylsulfonyl fluoride; 

Phrase: "PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.300: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.301: GPIb, glycoprotein Ib; 

Phrase: "GPIb,"

Phrase: "glycoprotein Ib"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032190:Glycoprotein Ib [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: ";"
Processing 00000000.tx.302: PVDF, polyvinylidine difluoride; 

Phrase: "PVDF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071710:PVDF [Organic Chemical]

Phrase: "polyvinylidine difluoride"

Phrase: ";"
Processing 00000000.tx.303: mAb, monoclonal antibody; 

Phrase: "mAb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: ";"
Processing 00000000.tx.304: GC, glycocalicin. 

Phrase: "GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3537453:GC [Gene or Genome]

Phrase: "glycocalicin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0061621:glycocalicin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.305: Q-X. 

Phrase: "Q-X."
Processing 00000000.tx.306: Li and C. 

Phrase: "Li"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.307: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.308: Masters, unpublished results. 

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "unpublished results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.309: Q-X. 

Phrase: "Q-X."
Processing 00000000.tx.310: Li and C. 

Phrase: "Li"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.311: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.312: Masters, unpublished observation. 

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "unpublished observation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.313: ACKNOWLEDGEMENTS We are grateful to Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Dr."
Processing 00000000.tx.314: Sam Gandy (Cornell University Medical College, New York) for the generous supply of the rabbit polyclonal antibody 369A. 

Phrase: "Sam Gandy (Cornell University Medical College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0557806:College [Manufactured Object]

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ")"

Phrase: "for the generous supply"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0243163:supply [Idea or Concept]
   861   C0699914:supply [Quantitative Concept]
   861   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   861   C1561604:supply [Functional Concept]
   861   C1875802:SUPPLY [Medical Device]
   861   C1999230:Supply [Activity]

Phrase: "of the rabbit polyclonal antibody 369A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.315: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.316: Michael Berndt for critical review of this manuscript. 

Phrase: "Michael Berndt for critical review of this manuscript."
Processing 00000000.tx.317: We are grateful to Dr. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Dr."
Processing 00000000.tx.318: Jon Currie and Valcy Malone of the Mental Health Research Institute of Victoria, Melbourne, Australia, for coordination of volunteers. 

Phrase: "Jon Currie"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1440524:Curry [Immunologic Factor]

Phrase: "and"

Phrase: "Valcy Malone of the Mental Health Research Institute of Victoria,"

Phrase: "Melbourne,"

Phrase: "Australia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: "for coordination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242414:Coordination [Physiologic Function]
  1000   C0700114:Coordination [Functional Concept]

Phrase: "of volunteers."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0042960:Volunteers [Professional or Occupational Group]
   966 E C1549078:Volunteer [Idea or Concept]
   966 E C1997894:volunteer [Population Group]
Processing 00000000.tx.319: Note Added in Proof-A calpain inhibitor (MDL 28170) has been reported to block A4 amyloid production in an APP-transfected cell line (Higaki, J., Quon, D., Zhong, Z., and Cordell, B.(1995) Neuron 14, 651-659). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Added in Proof-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0556981:% proof [Quantitative Concept]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "A calpain inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(MDL 28170"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165174:MDL 28170 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "A4 amyloid production in an APP-transfected cell line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0033268:production [Occupational Activity]

Phrase: "(Higaki,"

Phrase: "J.,"

Phrase: "Quon,"

Phrase: "D."

Phrase: ","

Phrase: "Zhong,"

Phrase: "Z.,"

Phrase: "and"

Phrase: "Cordell,"

Phrase: "B.(1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: "Neuron 14,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "651-659"

Phrase: ")."
Processing 00000000.tx.320: REFERENCES Ariyoshi, H., Shiba, E., Kambayashi, J., Sakon, M., Tsujinaka, T., Uemura, Y., and Mori, T.(1991) Biochem. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Ariyoshi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shiba,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1632313:shiba [Plant]

Phrase: "E.,"

Phrase: "Kambayashi,"

Phrase: "J.,"

Phrase: "Sakon,"

Phrase: "M."

Phrase: ","

Phrase: "Tsujinaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Uemura,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Mori,"

Phrase: "T.(1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.321: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.322: 23, 1019-1033 [Medline] [OrderarticleviaInfotrieve] Ashall, F., and Goate, A. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "1019-1033"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450318:1019 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ashall,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Goate,"

Phrase: "A."
Processing 00000000.tx.323: M.(1994) Trends Biochem. 

Phrase: "M.("

Phrase: "1994"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.324: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.325: 19, 42-46 [CrossRef][Medline] [OrderarticleviaInfotrieve] Berndt, M. 

Phrase: "19,"

Phrase: "42-46"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Berndt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.326: C., Gregory, C., Kabral, A., Zola, H., Fournier, D., and Castadli, P. 

Phrase: "C., Gregory,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kabral,"

Phrase: "A.,"

Phrase: "Zola,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fournier,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Castadli,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.327: A.(1985) Eur. 

Phrase: "A.(1985"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.328: J. 

Phrase: "J."
Processing 00000000.tx.329: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.330: 151, 637-649 [Abstract] Busciglio, J., Gabuzda, D. 

Phrase: "151,"

Phrase: "637-649"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Busciglio,"

Phrase: "J.,"

Phrase: "Gabuzda,"

Phrase: "D."
Processing 00000000.tx.331: H., Matsudaira, P., and Yankner, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Matsudaira,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.332: A. 

Phrase: "A."
Processing 00000000.tx.333: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.334: Natl. 

Phrase: "Natl."
Processing 00000000.tx.335: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.336: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.337: U. 

Phrase: "U."
Processing 00000000.tx.338: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.339: A. 

Phrase: "A."
Processing 00000000.tx.340: 90, 2092-2096 [Abstract] Bush, A. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "2092-2096"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.341: I., Martins, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.342: N., Rumble, B., Moir, R., Fuller, S., Milward, E., Currie, J., Ames, D., Weidemann, A., Fischer, P., Multhaup, G., Beyreuther, K., and Masters, C. 

Phrase: "N., Rumble,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Moir,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fuller,"

Phrase: "S."

Phrase: ","

Phrase: "Milward,"

Phrase: "E.,"

Phrase: "Currie,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440524:Curry [Immunologic Factor]

Phrase: "J.,"

Phrase: "Ames,"

Phrase: "D."

Phrase: ","

Phrase: "Weidemann,"

Phrase: "A.,"

Phrase: "Fischer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.343: L.(1990) J. 

Phrase: "L.(1990"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.344: Biol. 

Phrase: "Biol."
Processing 00000000.tx.345: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.346: 265, 15977-15983 [Abstract/Free FullText] Buxbaum, J. 

Phrase: "265,"

Phrase: "15977-15983"

Phrase: "[Abstract/Free FullText"

Phrase: "] Buxbaum,"

Phrase: "J."
Processing 00000000.tx.347: D., Gandy, S. 

Phrase: "D."

Phrase: ","

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.348: E., Cicchetti, P., Ehrlich, M. 

Phrase: "E.,"

Phrase: "Cicchetti,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ehrlich,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.349: E., Czernik, A. 

Phrase: "E.,"

Phrase: "Czernik,"

Phrase: "A."
Processing 00000000.tx.350: J., Fracasso, R. 

Phrase: "J.,"

Phrase: "Fracasso,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.351: P., Ramabhadran, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ramabhadran,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.352: V., Unterbeck, A. 

Phrase: "V., Unterbeck,"

Phrase: "A."
Processing 00000000.tx.353: J., and Greengard, P.(1990) Proc. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P.(1990"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.354: Natl. 

Phrase: "Natl."
Processing 00000000.tx.355: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.356: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.357: U. 

Phrase: "U."
Processing 00000000.tx.358: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.359: A. 

Phrase: "A."
Processing 00000000.tx.360: 87, 6003-6006 [Abstract] Buxbaum, J. 

Phrase: "87,"

Phrase: "6003-6006"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Buxbaum,"

Phrase: "J."
Processing 00000000.tx.361: D., Ruefli, A. 

Phrase: "D."

Phrase: ","

Phrase: "Ruefli,"

Phrase: "A."
Processing 00000000.tx.362: A., Parker, C. 

Phrase: "A.,"

Phrase: "Parker,"

Phrase: "C."
Processing 00000000.tx.363: A., Cypess, A. 

Phrase: "A.,"

Phrase: "Cypess,"

Phrase: "A."
Processing 00000000.tx.364: M., and Greengard, P.(1994) Proc. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P.(1994"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.365: Natl. 

Phrase: "Natl."
Processing 00000000.tx.366: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.367: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.368: U. 

Phrase: "U."
Processing 00000000.tx.369: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.370: A. 

Phrase: "A."
Processing 00000000.tx.371: 91, 4489-4493 [Abstract] Cai, X., Golde, T. 

Phrase: "91,"

Phrase: "4489-4493"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.,"

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.372: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.373: G.(1993) Science 259, 514-516 [Medline] [OrderarticleviaInfotrieve] Caporaso, G. 

Phrase: "G.(1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Science 259,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "514-516"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Caporaso,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.374: L., Gandy, S. 

Phrase: "L., Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.375: E., Buxbaum, J. 

Phrase: "E.,"

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.376: D., and Greengard, P.(1992) Proc. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P.(1992"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.377: Natl. 

Phrase: "Natl."
Processing 00000000.tx.378: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.379: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.380: U. 

Phrase: "U."
Processing 00000000.tx.381: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.382: A. 

Phrase: "A."
Processing 00000000.tx.383: 89, 2252-2256 [Abstract] Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. 

Phrase: "89,"

Phrase: "2252-2256"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.384: Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.385: J.(1992) Nature 360, 672-674 [CrossRef][Medline] [OrderarticleviaInfotrieve] Cole, G. 

Phrase: "J.(1992"

Phrase: ")"

Phrase: "Nature 360,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "672-674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cole,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.386: M., Galasko, D., Shapiro, I. 

Phrase: "M."

Phrase: ","

Phrase: "Galasko,"

Phrase: "D."

Phrase: ","

Phrase: "Shapiro,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.387: P., and Saitoh, T.(1990) Biochem. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T.(1990"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.388: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.389: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.390: Commun. 

Phrase: "Commun."
Processing 00000000.tx.391: 170, 288-295 [Medline] [OrderarticleviaInfotrieve] Esch, F. 

Phrase: "170,"

Phrase: "288-295"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Esch,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.392: S., Keim, P. 

Phrase: "S."

Phrase: ","

Phrase: "Keim,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.393: S., Beattie, E. 

Phrase: "S."

Phrase: ","

Phrase: "Beattie,"

Phrase: "E."
Processing 00000000.tx.394: C., Blacher, R. 

Phrase: "C., Blacher,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.395: W., Culwell, A. 

Phrase: "W., Culwell,"

Phrase: "A."
Processing 00000000.tx.396: R., Oltersdorf, T., McClure, D., and Ward, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "McClure,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.397: J.(1990) Science 248, 1122-1124 [Medline] [OrderarticleviaInfotrieve] Evin, G., Beyreuther, K., and Masters, C. 

Phrase: "J.(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1122-1124"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Evin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.398: L.(1994) Amyloid: Int. 

Phrase: "L.(1994"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.399: J. 

Phrase: "J."
Processing 00000000.tx.400: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.401: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.402: Invest., 1, 263-280 Fox, J. 

Phrase: "Invest.,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "263-280 Fox,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016633:Fox [Mammal]
   755 E C0049564:FOXY [Organic Chemical]

Phrase: "J."
Processing 00000000.tx.403: E. 

Phrase: "E."
Processing 00000000.tx.404: B., Reynolds, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Reynolds,"

Phrase: "C."
Processing 00000000.tx.405: C., and Austin, C. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Austin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0605411:austin [Organic Chemical]

Phrase: "C."
Processing 00000000.tx.406: D.(1990) Blood 76, 2510-2519 [Abstract] Fox, J. 

Phrase: "D.("

Phrase: "1990"

Phrase: ")"

Phrase: "Blood 76,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "2510-2519"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fox,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016633:Fox [Mammal]
   928 E C0049564:FOXY [Organic Chemical]

Phrase: "J."
Processing 00000000.tx.407: E. 

Phrase: "E."
Processing 00000000.tx.408: B., Goll, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Goll,"

Phrase: "D."
Processing 00000000.tx.409: E., Reynolds, C. 

Phrase: "E.,"

Phrase: "Reynolds,"

Phrase: "C."
Processing 00000000.tx.410: C., and Phillips, D. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Phillips,"

Phrase: "D."
Processing 00000000.tx.411: R.(1985) J. 

Phrase: "R.(1985"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.412: Biol. 

Phrase: "Biol."
Processing 00000000.tx.413: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.414: 260, 1060-1066 [Abstract/Free FullText] Furukawa, K., Oyama, Y., Chikahisa, L., Hatakeyama, Y., and Akaike, N. 

Phrase: "260,"

Phrase: "1060-1066"

Phrase: "[Abstract/Free FullText"

Phrase: "] Furukawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Oyama,"

Phrase: "Y.,"

Phrase: "Chikahisa,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hatakeyama,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Akaike,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.415: (1994) Brain Res. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.416: 662, 259-262 [Medline] [OrderarticleviaInfotrieve] Gardella, J. 

Phrase: "662,"

Phrase: "259-262"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gardella,"

Phrase: "J."
Processing 00000000.tx.417: E., Gorgone, G. 

Phrase: "E.,"

Phrase: "Gorgone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2807028:Gorgone [Eukaryote]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.418: A., Munoz, P. 

Phrase: "A.,"

Phrase: "Munoz,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.419: C., Ghiso, J., Frangione, B., and Gorevic, P. 

Phrase: "C., Ghiso,"

Phrase: "J.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Gorevic,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.420: D.(1992) Lab. 

Phrase: "D.("

Phrase: "1992"

Phrase: ")"

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.421: Invest. 

Phrase: "Invest."
Processing 00000000.tx.422: 67, 303-313 [Medline] [OrderarticleviaInfotrieve] Ghiso, J., Gardella, J. 

Phrase: "67,"

Phrase: "303-313"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ghiso,"

Phrase: "J.,"

Phrase: "Gardella,"

Phrase: "J."
Processing 00000000.tx.423: E., Liem, L., Gorevic, P. 

Phrase: "E.,"

Phrase: "Liem,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gorevic,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.424: D., and Frangione, B. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.425: (1994) Neurosci. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.426: Lett. 

Phrase: "Lett."
Processing 00000000.tx.427: 171, 213-216 [Medline] [OrderarticleviaInfotrieve] Golde, T. 

Phrase: "171,"

Phrase: "213-216"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.428: E., Estus, S., Younkin, L. 

Phrase: "E.,"

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "Younkin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.429: H., Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.430: J., and Younkin, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.431: G.(1992) Science 255, 728-730 [Medline] [OrderarticleviaInfotrieve] Haass, C., Koo, E. 

Phrase: "G.(1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Science 255,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "728-730"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.432: H., Mellon, A., Hung, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mellon,"

Phrase: "A.,"

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.433: Y., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.434: J. 

Phrase: "J."
Processing 00000000.tx.435: (1992) Nature 357, 500-503 [CrossRef][Medline] [OrderarticleviaInfotrieve] Haass, C., Hung, A. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 357,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "500-503"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.436: Y., Schlossmacher, M. 

Phrase: "Y.,"

Phrase: "Schlossmacher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.437: G., Teplow, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.438: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.439: J.(1993) J. 

Phrase: "J.(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.440: Biol. 

Phrase: "Biol."
Processing 00000000.tx.441: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.442: 268, 3021-3024 [Abstract/Free FullText] Haass, C., Hung, A. 

Phrase: "268,"

Phrase: "3021-3024"

Phrase: "[Abstract/Free FullText"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.443: H., Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.444: J., and Teplow, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.445: B.(1994) J. 

Phrase: "B.(1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.446: Biol. 

Phrase: "Biol."
Processing 00000000.tx.447: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.448: 269, 17741-17748 [Abstract/Free FullText] Hilbich, C., Mnning, U., Grund, C., Masters, C. 

Phrase: "269,"

Phrase: "17741-17748"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hilbich,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mnning,"

Phrase: "U.,"

Phrase: "Grund,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.449: L., and Beyreuther, K.(1993) J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K.(1993"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.450: Biol. 

Phrase: "Biol."
Processing 00000000.tx.451: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.452: 268, 26571-26577 [Abstract/Free FullText] Kang, J., Lemaire, H., Unterbeck, A., Salbaum, J. 

Phrase: "268,"

Phrase: "26571-26577"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kang,"

Phrase: "J.,"

Phrase: "Lemaire,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.453: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.454: L., Grzeschik, K., Multhaup, G., Beyreuther, K., and Mller-Hill, B. 

Phrase: "L., Grzeschik,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mller-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.455: (1987) Nature 325, 733-736 [CrossRef][Medline] [OrderarticleviaInfotrieve] Kim, K. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Nature 325,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "733-736"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.456: S., Wen, G. 

Phrase: "S."

Phrase: ","

Phrase: "Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.457: Y., Bancher, C., Chen, C. 

Phrase: "Y.,"

Phrase: "Bancher,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "C."
Processing 00000000.tx.458: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.459: J., Sapienza, V. 

Phrase: "J.,"

Phrase: "Sapienza,"

Phrase: "V."
Processing 00000000.tx.460: J., Hong, H., and Wisniewski, H. 

Phrase: "J.,"

Phrase: "Hong,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wisniewski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.461: M.(1990) Neurosci. 

Phrase: "M.("

Phrase: "1990"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.462: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.463: Commun. 

Phrase: "Commun."
Processing 00000000.tx.464: 7, 113-122 Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., and Ito, H. 

Phrase: "7,"

Phrase: "113-122 Kitaguchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "Y.,"

Phrase: "Tokushima,"

Phrase: "Y.,"

Phrase: "Shiojiri,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.465: (1988) Nature 331, 530-532 [CrossRef][Medline] [OrderarticleviaInfotrieve] Knops, J., Lieberburg, I., and Sinha, S.(1992) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Nature 331,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "530-532"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Knops,"

Phrase: "J.,"

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Sinha,"

Phrase: "S.("

Phrase: "1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.466: Biol. 

Phrase: "Biol."
Processing 00000000.tx.467: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.468: 267, 16022-16024 [Abstract/Free FullText] Koo, E. 

Phrase: "267,"

Phrase: "16022-16024"

Phrase: "[Abstract/Free FullText"

Phrase: "] Koo,"

Phrase: "E."
Processing 00000000.tx.469: H., and Squazzo, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Squazzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.470: L.(1994) J. 

Phrase: "L.(1994"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.471: Biol. 

Phrase: "Biol."
Processing 00000000.tx.472: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.473: 269, 17386-17389 [Abstract/Free FullText] Kuentzel, S. 

Phrase: "269,"

Phrase: "17386-17389"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuentzel,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.474: L., Ali, S. 

Phrase: "L., Ali,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.475: M., Altman, R. 

Phrase: "M."

Phrase: ","

Phrase: "Altman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.476: A., Greenberg, B. 

Phrase: "A.,"

Phrase: "Greenberg,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.477: D., and Raub, T. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Raub,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.478: J.(1993) Biochem. 

Phrase: "J.(1993"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.479: J. 

Phrase: "J."
Processing 00000000.tx.480: 295, 367-378 [Medline] [OrderarticleviaInfotrieve] Knig, G., Mnning, U., Czech, C., Prior, R., Banati, R., Schreiter-Gasser, U., Bauer, J., Masters, C. 

Phrase: "295,"

Phrase: "367-378"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Knig,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mnning,"

Phrase: "U.,"

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Prior,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Prior [Temporal Concept]
  1000   C2826257:PRIOR [Event]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Banati,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Schreiter-Gasser,"

Phrase: "U.,"

Phrase: "Bauer,"

Phrase: "J.,"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.481: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.482: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.483: Biol. 

Phrase: "Biol."
Processing 00000000.tx.484: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.485: 267, 10804-10809 [Abstract/Free FullText] Li, Q.-X., Berndt, M. 

Phrase: "267,"

Phrase: "10804-10809"

Phrase: "[Abstract/Free FullText"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Q.-X.,"

Phrase: "Berndt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.486: C., Bush, A. 

Phrase: "C., Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.487: I., Rumble, B., Mackenzie, I., Friedhuber, A., Beyreuther, K., and Masters, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rumble,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Mackenzie,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Friedhuber,"

Phrase: "A.,"

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.488: L.(1994) Blood 84, 133-142 [Abstract/Free FullText] Matsumoto, A., and Fujiwara, Y.(1993) Eur. 

Phrase: "L.(1994"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: "Blood 84,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "133-142"

Phrase: "[Abstract/Free FullText"

Phrase: "] Matsumoto,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Fujiwara,"

Phrase: "Y.(1993"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.489: J. 

Phrase: "J."
Processing 00000000.tx.490: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.491: 217, 21-27 [Abstract] Mattson, M. 

Phrase: "217,"

Phrase: "21-27"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.492: P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cheng,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Davis,"

Phrase: "D."

Phrase: ","

Phrase: "Bryant,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Rydel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.493: E.(1992) J. 

Phrase: "E.(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.494: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.495: 12, 376-389 [Abstract] McGowan, E. 

Phrase: "12,"

Phrase: "376-389"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McGowan,"

Phrase: "E."
Processing 00000000.tx.496: B., Yeo, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Yeo,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.497: T., and Detwiler, T. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Detwiler,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.498: C.(1983) Arch. 

Phrase: "C.(1983"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.499: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.500: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.501: 227, 287-301 [Medline] [OrderarticleviaInfotrieve] Moir, R. 

Phrase: "227,"

Phrase: "287-301"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.502: D., Martins, R. 

Phrase: "D."

Phrase: ","

Phrase: "Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.503: N., Small, D. 

Phrase: "N., Small, D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C1513911:N.D. [Intellectual Product]
Processing 00000000.tx.504: H., Bush, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.505: I., Milward, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Milward,"

Phrase: "E."
Processing 00000000.tx.506: A., Multhaup, G., Beyreuther, K., and Masters, C. 

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.507: L.(1992) J. 

Phrase: "L.(1992"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.508: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.509: 59, 1490-1498 [Medline] [OrderarticleviaInfotrieve] Nilsson, E., Alafuzoff, I., Blennow, K., Blomgren, K., Hall, C. 

Phrase: "59,"

Phrase: "1490-1498"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nilsson,"

Phrase: "E.,"

Phrase: "Alafuzoff,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Blennow,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Blomgren,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hall,"

Phrase: "C."
Processing 00000000.tx.510: M., Janson, I., Karlsson, I., Wallin, A., Gottfries, C. 

Phrase: "M."

Phrase: ","

Phrase: "Janson,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Karlsson,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Wallin,"

Phrase: "A.,"

Phrase: "Gottfries,"

Phrase: "C."
Processing 00000000.tx.511: G., and Karlsson, J.-O.(1990) Neurobiol. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Karlsson,"

Phrase: "J.-O.(1990"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.512: Aging 11, 425-431 [CrossRef][Medline] [OrderarticleviaInfotrieve] Nordstedt, C., Gandy, S. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "11,"

Phrase: "425-431"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.513: E., Alafuzoff, I., Caporaso, G. 

Phrase: "E.,"

Phrase: "Alafuzoff,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Caporaso,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.514: L., Iverfeldt, K., Grebb, J. 

Phrase: "L., Iverfeldt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Grebb,"

Phrase: "J."
Processing 00000000.tx.515: A., Winblad, B., and Greengard, P.(1991) Proc. 

Phrase: "A.,"

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P.(1991"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.516: Natl. 

Phrase: "Natl."
Processing 00000000.tx.517: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.518: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.519: U. 

Phrase: "U."
Processing 00000000.tx.520: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.521: A. 

Phrase: "A."
Processing 00000000.tx.522: 88, 8910-8914 [Abstract] Oda, A., Druker, B. 

Phrase: "88,"

Phrase: "8910-8914"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Druker,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.523: J., Ariyoshi, H., Smith, M., and Salzman, E. 

Phrase: "J.,"

Phrase: "Ariyoshi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Salzman,"

Phrase: "E."
Processing 00000000.tx.524: W. 

Phrase: "W."
Processing 00000000.tx.525: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.526: Biol. 

Phrase: "Biol."
Processing 00000000.tx.527: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.528: 268, 12603-12608 [Abstract/Free FullText] Peterson, C., Ratan, R. 

Phrase: "268,"

Phrase: "12603-12608"

Phrase: "[Abstract/Free FullText"

Phrase: "] Peterson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ratan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.529: R., Shelanski, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Shelanski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.530: L., and Goldman, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Goldman,"

Phrase: "J."
Processing 00000000.tx.531: E.(1986) Proc. 

Phrase: "E.(1986"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.532: Natl. 

Phrase: "Natl."
Processing 00000000.tx.533: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.534: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.535: U. 

Phrase: "U."
Processing 00000000.tx.536: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.537: A. 

Phrase: "A."
Processing 00000000.tx.538: 83, 7999-8001 [Abstract] Peterson, C., Vanderklish, P., Seubert, P., Cotman, C., and Lynch, G. 

Phrase: "83,"

Phrase: "7999-8001"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Peterson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Vanderklish,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cotman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Lynch,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.539: (1991) Neurosci. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.540: Lett. 

Phrase: "Lett."
Processing 00000000.tx.541: 121, 239-243 [Medline] [OrderarticleviaInfotrieve] Phillips, D. 

Phrase: "121,"

Phrase: "239-243"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Phillips,"

Phrase: "D."
Processing 00000000.tx.542: R., and Jakabova, M.(1977) J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Jakabova,"

Phrase: "M.("

Phrase: "1977"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.543: Biol. 

Phrase: "Biol."
Processing 00000000.tx.544: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.545: 252, 5602-5605 [Abstract] Ponte, P., Gonzalez-DeWhitt, P., Schilling, J., Miller, J., Hsu, D., Greenberg, B., Davis, K., Wallace, W., Lieberburg, I., Fuller, F., and Cordell, B.(1988) Nature 331, 525-527 [CrossRef][Medline] [OrderarticleviaInfotrieve] Querfurth, H. 

Phrase: "252,"

Phrase: "5602-5605"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ponte,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gonzalez-DeWhitt,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schilling,"

Phrase: "J.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "J.,"

Phrase: "Hsu,"

Phrase: "D."

Phrase: ","

Phrase: "Greenberg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Davis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "W.,"

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fuller,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Cordell,"

Phrase: "B.(1988"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: "Nature 331,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "525-527"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Querfurth,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.546: W., and Selkoe, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.547: J.(1994) Biochemistry 33, 4550-4561 [Medline] [OrderarticleviaInfotrieve] Saido, T. 

Phrase: "J.(1994"

Phrase: ")"

Phrase: "Biochemistry 33,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4550-4561"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.548: C., Suzuki, H., Yamazaki, H., Tanoue, K., and Suzuki, K. 

Phrase: "C., Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0998924:suzuki [Fish]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamazaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tanoue,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.549: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.550: Biol. 

Phrase: "Biol."
Processing 00000000.tx.551: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.552: 268, 7422-7426 [Abstract/Free FullText] Saido, T. 

Phrase: "268,"

Phrase: "7422-7426"

Phrase: "[Abstract/Free FullText"

Phrase: "] Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.553: C., Sorimachi, H., and Suzuki, K.(1994) FASEB J. 

Phrase: "C., Sorimachi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.(1994"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.554: 8, 814-822 [Abstract/Free FullText] Saito, K., Elce, J. 

Phrase: "8,"

Phrase: "814-822"

Phrase: "[Abstract/Free FullText"

Phrase: "] Saito,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Elce,"

Phrase: "J."
Processing 00000000.tx.555: S., Hamos, J. 

Phrase: "S."

Phrase: ","

Phrase: "Hamos,"

Phrase: "J."
Processing 00000000.tx.556: E., and Nixon, R. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Nixon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.557: A.(1993) Proc. 

Phrase: "A.(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.558: Natl. 

Phrase: "Natl."
Processing 00000000.tx.559: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.560: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.561: U. 

Phrase: "U."
Processing 00000000.tx.562: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.563: A. 

Phrase: "A."
Processing 00000000.tx.564: 90, 2628-2632 [Abstract] Sandbrink, R., Masters, C. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "2628-2632"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sandbrink,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.565: L., and Beyreuther, K.(1994) J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K.(1994"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.566: Biol. 

Phrase: "Biol."
Processing 00000000.tx.567: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.568: 269, 1510-1517 [Abstract/Free FullText] Sasaki, T., Kishi, M., Saito, M., Tanaka, T., Higuchi, N., Kominama, E., Katunuma, N., and Murachi, T.(1990) J. 

Phrase: "269,"

Phrase: "1510-1517"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sasaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kishi,"

Phrase: "M."

Phrase: ","

Phrase: "Saito,"

Phrase: "M."

Phrase: ","

Phrase: "Tanaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Higuchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kominama,"

Phrase: "E.,"

Phrase: "Katunuma,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Murachi,"

Phrase: "T.(1990"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.569: Enzyme Inhib. 

Phrase: "Enzyme Inhib."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1628982:% inhib [Quantitative Concept]
Processing 00000000.tx.570: 3, 195-201 [Medline] [OrderarticleviaInfotrieve] Schlossmacher, M. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "195-201"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schlossmacher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.571: G., Ostaszewski, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.572: L., Hecker, L. 

Phrase: "L., Hecker,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.573: I., Celi, A., Haass, C., Chin, D., Lieberburg, I., Furie, B. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Celi,"

Phrase: "A.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Chin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008114:Chin [Body Location or Region]
  1000   C1284862:Chin [Body Location or Region]

Phrase: "D."

Phrase: ","

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Furie,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.574: C., Furie, B., and Selkoe, D. 

Phrase: "C., Furie,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.575: J.(1992) Neurobiol. 

Phrase: "J.(1992"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.576: Aging 13, 421-434 [CrossRef][Medline] [OrderarticleviaInfotrieve] Seubert, P., Oltersdorf, T., Lee, M. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "13,"

Phrase: "421-434"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.577: G., Barbour, R., Blomquist, C., Davis, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Blomquist,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Davis,"

Phrase: "D."
Processing 00000000.tx.578: L., Bryant, K., Fritz, L. 

Phrase: "L., Bryant,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fritz,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414819:FRITZ [Gene or Genome]
  1000   C2681211:fritz [Gene or Genome]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.579: C., Galasko, D., Thal, L. 

Phrase: "C., Galasko,"

Phrase: "D."

Phrase: ","

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.580: J., Lieberburg, I., and Schenk, D. 

Phrase: "J.,"

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.581: B.(1993) Nature 361, 260-263 [CrossRef][Medline] [OrderarticleviaInfotrieve] Shoji, M., Golde, T. 

Phrase: "B.(1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: "Nature 361,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "260-263"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.582: E., Ghiso, J., Cheung, T. 

Phrase: "E.,"

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.583: T., Estus, S., Shaffer, L. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "Shaffer,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.584: M., Cai, X., McKay, D. 

Phrase: "M."

Phrase: ","

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.,"

Phrase: "McKay,"

Phrase: "D."
Processing 00000000.tx.585: M., Tintner, R., Frangione, B., and Younkin, S. 

Phrase: "M."

Phrase: ","

Phrase: "Tintner,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.586: G.(1992) Science 258, 126-129 [Medline] [OrderarticleviaInfotrieve] Sisodia, S. 

Phrase: "G.(1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Science 258,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "126-129"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.587: S.(1992) Proc. 

Phrase: "S.("

Phrase: "1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.588: Natl. 

Phrase: "Natl."
Processing 00000000.tx.589: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.590: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.591: U. 

Phrase: "U."
Processing 00000000.tx.592: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.593: A. 

Phrase: "A."
Processing 00000000.tx.594: 89, 6075-6079 [Abstract] Sisodia, S. 

Phrase: "89,"

Phrase: "6075-6079"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.595: S., Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.596: H., Beyreuther, K., Unterbeck, A., and Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.597: L.(1990) Science 248, 492-495 [Medline] [OrderarticleviaInfotrieve] Smith, R. 

Phrase: "L.(1990"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "492-495"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.598: P. and Broze, G. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Broze,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.599: J., Jr.(1992) Blood 80, 2252-2260 [Abstract] Smith, R. 

Phrase: "J.,"

Phrase: "Jr.(1992"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: ")"

Phrase: "Blood 80,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "2252-2260"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.600: P., Higuchi, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Higuchi,"

Phrase: "D."
Processing 00000000.tx.601: A., and Broze, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Broze,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.602: J.(1990) Science 248, 1126-1128 [Medline] [OrderarticleviaInfotrieve] Sprecher, C. 

Phrase: "J.(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1126-1128"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sprecher,"

Phrase: "C."
Processing 00000000.tx.603: A., Grant, F. 

Phrase: "A.,"

Phrase: "Grant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.604: J., Grimm, G., O'Hara, P. 

Phrase: "J.,"

Phrase: "Grimm,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "O'Hara,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439114:O NOS [Intellectual Product]
   861   C2758676:Hara [Fish]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.605: J., Norris, F., Norris, K., and Foster, D. 

Phrase: "J.,"

Phrase: "Norris,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Norris,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "D."
Processing 00000000.tx.606: C.(1993) Biochemistry 32, 4481-4486 [Medline] [OrderarticleviaInfotrieve] Suzuki, N., Cheung, T. 

Phrase: "C.(1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "Biochemistry 32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4481-4486"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.607: T., Cai, X. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.608: D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.609: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.610: G.(1994) Science 264, 1336-1340 [Medline] [OrderarticleviaInfotrieve] Tamaoka, A., Kalaria, R. 

Phrase: "G.(1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1336-1340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tamaoka,"

Phrase: "A.,"

Phrase: "Kalaria,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.611: N., Lieberburg, I., and Selkoe, D. 

Phrase: "N., Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.612: J.(1992) Proc. 

Phrase: "J.(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.613: Natl. 

Phrase: "Natl."
Processing 00000000.tx.614: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.615: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.616: U. 

Phrase: "U."
Processing 00000000.tx.617: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.618: A. 

Phrase: "A."
Processing 00000000.tx.619: 89, 1345-1349 [Abstract] Tanzi, R. 

Phrase: "89,"

Phrase: "1345-1349"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.620: E., McClatchey, A. 

Phrase: "E.,"

Phrase: "McClatchey,"

Phrase: "A."
Processing 00000000.tx.621: I., Lamperti, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lamperti,"

Phrase: "E."
Processing 00000000.tx.622: D., Villa-Komaroff, L., Gusella, J. 

Phrase: "D."

Phrase: ","

Phrase: "Villa-Komaroff,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gusella,"

Phrase: "J."
Processing 00000000.tx.623: F., and Neve, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Neve,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.624: L.(1988) Nature 331, 528-530 [CrossRef][Medline] [OrderarticleviaInfotrieve] Tsujinaka, T., Kajiwara, Y., Kambayashi, J., Sakon, M., Higuchi, N., Tanaka, T., and Mori, T.(1988) Biochem. 

Phrase: "L.(1988"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: "Nature 331,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "528-530"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tsujinaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kajiwara,"

Phrase: "Y.,"

Phrase: "Kambayashi,"

Phrase: "J.,"

Phrase: "Sakon,"

Phrase: "M."

Phrase: ","

Phrase: "Higuchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tanaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Mori,"

Phrase: "T.(1988"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.625: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.626: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.627: Commun. 

Phrase: "Commun."
Processing 00000000.tx.628: 153, 1201-1208 Van Nostrand, W. 

Phrase: "153,"

Phrase: "1201-1208 Van Nostrand,"

Phrase: "W."
Processing 00000000.tx.629: E., Schmaier, A. 

Phrase: "E.,"

Phrase: "Schmaier,"

Phrase: "A."
Processing 00000000.tx.630: H., Farrow, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Farrow,"

Phrase: "J."
Processing 00000000.tx.631: S., Cines, D. 

Phrase: "S."

Phrase: ","

Phrase: "Cines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1979871:Cine [Diagnostic Procedure]
   966   C2986727:Cine [Functional Concept]

Phrase: "D."
Processing 00000000.tx.632: B., and Cunningham, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Cunningham,"

Phrase: "D."
Processing 00000000.tx.633: D.(1991) Biochem. 

Phrase: "D.("

Phrase: "1991"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.634: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.635: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.636: Commun. 

Phrase: "Commun."
Processing 00000000.tx.637: 175, 15-21 [Medline] [OrderarticleviaInfotrieve] Wasco, W., Bupp, K., Magendantz, M., Gusella, J. 

Phrase: "175,"

Phrase: "15-21"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wasco,"

Phrase: "W.,"

Phrase: "Bupp,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Magendantz,"

Phrase: "M."

Phrase: ","

Phrase: "Gusella,"

Phrase: "J."
Processing 00000000.tx.638: F., Tanzi, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.639: E., and Solomon, F.(1992) Proc. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Solomon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551833:Solomon [Population Group]

Phrase: "F.(1992"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.640: Natl. 

Phrase: "Natl."
Processing 00000000.tx.641: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.642: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.643: U. 

Phrase: "U."
Processing 00000000.tx.644: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.645: A. 

Phrase: "A."
Processing 00000000.tx.646: 89, 10758-10762 [Abstract] Weidemann, A., Knig, G., Bunke, D., Fischer, P., Salbaum, J. 

Phrase: "89,"

Phrase: "10758-10762"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Weidemann,"

Phrase: "A.,"

Phrase: "Knig,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bunke,"

Phrase: "D."

Phrase: ","

Phrase: "Fischer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.647: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.648: L., and Beyreuther, K.(1989) Cell 57, 115-126 [Medline] [OrderarticleviaInfotrieve] Yano, Y., Shiba, E., Kambayashi, J., Sakon, M., Kawasaki, T., Fujitani, K., Kang, J., and Mori, T.(1993) Thromb. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K.(1989"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "Cell 57,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "115-126"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yano,"

Phrase: "Y.,"

Phrase: "Shiba,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1632313:shiba [Plant]

Phrase: "E.,"

Phrase: "Kambayashi,"

Phrase: "J.,"

Phrase: "Sakon,"

Phrase: "M."

Phrase: ","

Phrase: "Kawasaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fujitani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kang,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Mori,"

Phrase: "T.(1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: "Thromb."
Processing 00000000.tx.649: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.650: 71, 385-396 [Medline] [OrderarticleviaInfotrieve] Yoshida, N., Weksler, B., and Nachaman, R.(1983) J. 

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "385-396"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yoshida,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Weksler,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Nachaman,"

Phrase: "R.(1983"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.651: Biol. 

Phrase: "Biol."
Processing 00000000.tx.652: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.653: 258, 7168-7174 [Abstract/Free FullText] Zhong, Z., Quon, D., Higgins, L. 

Phrase: "258,"

Phrase: "7168-7174"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhong,"

Phrase: "Z.,"

Phrase: "Quon,"

Phrase: "D."

Phrase: ","

Phrase: "Higgins,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.654: S., Higaki, J., and Cordell, B.(1994) J. 

Phrase: "S."

Phrase: ","

Phrase: "Higaki,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Cordell,"

Phrase: "B.(1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.655: Biol. 

Phrase: "Biol."
Processing 00000000.tx.656: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.657: 269, 12179-12184 [Abstract/Free FullText] 1995 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "269,"

Phrase: "12179-12184"

Phrase: "[Abstract/Free FullText"

Phrase: "] 1995 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

